118 results on '"Yu-Jia Chang"'
Search Results
2. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer
- Author
-
Cheng-Chin Lee, Ai-Wei Lee, Po-Li Wei, Yi-Shin Liu, Yu-Jia Chang, and Chien-Yu Huang
- Subjects
Multidisciplinary - Abstract
Oxaliplatin (OXA) is the first-line chemotherapy drug for metastatic colorectal cancer (mCRC), and the emergence of drug resistance is a major clinical challenge. Although there have been numerous studies on OXA resistance, but its underlying molecular mechanisms are still unclear. This study aims to identify key regulatory genes and pathways associated with OXA resistance. The Gene Expression Omnibus (GEO) GSE42387 dataset containing gene expression profiles of parental and OXA-resistant LoVo cells was applied to explore potential targets. GEO2R, STRING, CytoNCA (a plug-in of Cytoscape), and DAVID were used to analyze differentially expressed genes (DEGs), protein–protein interactions (PPIs), hub genes in PPIs, and gene ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. R2 online platform was used to run a survival analysis of validated hub genes enriched in KEGG pathways. The ENCORI database predicted microRNAs for candidate genes. A survival analysis of those genes was performed, and validated using the OncoLnc database. In addition, the 'clusterProfiler' package in R was used to perform gene set enrichment analysis (GSEA). We identified 395 DEGs, among which 155 were upregulated and 240 were downregulated. In total, 95 DEGs were screened as hub genes after constructing the PPI networks. Twelve GO terms and three KEGG pathways (steroid hormone biosynthesis, malaria, and pathways in cancer) were identified as being significant in the enrichment analysis of hub genes. Twenty-one hub genes enriched in KEGG pathways were defined as key genes. Among them AKT3, phospholipase C Beta 4 (PLCB4), and TGFB1 were identified as OXA-resistance genes through the survival analysis. High expressions of AKT3 and TGFB1 were each associated with a poor prognosis, and lower expression of PLCB4 was correlated with worse survival. Further, high levels of hsa-miR-1271-5p, which potentially targets PLCB4, were associated with poor overall survival in patients with CRC. Finally, we found that PLCB4 low expression was associated with MAPK signaling pathway and VEGF signaling pathway in CRC. Our results demonstrated that hsa-miR-1271-5p/PLCB4 in the pathway in cancer could be a new potential therapeutic target for mCRC with OXA resistance.
- Published
- 2023
3. Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
- Author
-
Po-Li, Wei, Jang-Chun, Lin, Chin-Sheng, Hung, Precious Takondwa, Makondi, Uyanga, Batzorig, Tung-Cheng, Chang, Chien-Yu, Huang, and Yu-Jia, Chang
- Subjects
alpha-Defensins ,Epithelial-Mesenchymal Transition ,EGFR ,Gene Expression ,Kaplan-Meier Estimate ,migration ,S Phase ,Mice ,Plasminogen Activator Inhibitor 1 ,Biomarkers, Tumor ,Tumor Cells, Cultured ,Animals ,Humans ,Neoplasm Invasiveness ,Neoplasm Metastasis ,Cell Proliferation ,EGF ,Epidermal Growth Factor ,serpine-1 ,Cell Cycle Checkpoints ,General Medicine ,Colon cancer ,ErbB Receptors ,Disease Models, Animal ,progression ,Colorectal Neoplasms ,defensin6 ,Research Paper - Abstract
The incidence of colorectal cancer (CRC) has increased significantly in the past decade. Early diagnosis and new therapeutics are still urgently needed for CRC in clinical practice. Human α-defensin 6 (HD6) plays a defense role against microbes in the gastrointestinal tract. However, the role and mechanism of HD6 in CRC is still unresolved. Specimens from CRC patients with higher HD6 showed better outcomes. Overexpressed HD6 in CRC cells caused a reduction of cell proliferative, migratory, and invasive ability in vitro and in vivo. HD6-overexpressed caused S phase arrest through changes in cyclin-A and B and CDK2 levels. In addition, serpine-1 may be negatively regulated by HD6 altering the translocation of c-Jun N-terminal kinases (JNK), extracellular regulated protein kinases (ERK), and p38. Higher HD6 and lower serpine-1 levels in CRC patients reflected better outcomes. Finally, we found that HD6 interacts directly with epidermal growth factor receptor (EGFR) by co-immunoprecipitated assay. EGF treatment caused an increase of the level of serpine-1 and pEGFR levels and then increased growth activity in HD6 overexpressing cells. Together, our study shows that HD6 may compete with EGF to bind to EGFR and interrupt cancer progression in CRC. We believe these findings may give new insights for HD6 in CRC therapy.
- Published
- 2022
4. IL8 associated with M2 macrophage infiltration as a prognostic biomarker differentiates WHO grade III and grade IV gliomas
- Author
-
Jang-Chun Lin, Cheng-Chin Lee, Yu-Jia Chang, Ai-Wei Lee, Chien-Yu Huang, and Wei-Hsiu Liu
- Abstract
Malignant glioma can be divided into grade III (Gr. III) and grade IV (Gr. IV). Gr. III glioma patients have significantly better overall survival (OS) than those with Gr. IV glioma, also known as glioblastoma multiforme (GBM). We explored differentially expressed genes (DEGs) from the GSE4290 and GSE109857 datasets between Gr. III and Gr. IV gliomas. Six candidate prognostic genes for GBM were determined from survival analysis of data obtained from The Cancer Genome Atlas (TCGA), and the results were validated via assessments of the OS of Gr. III glioma and GBM patients using data obtained from the Chinese Glioma Genome Atlas (CGGA). Then, the expression levels of CXCL8, also named IL8, had a significant relationship with progression-free survival (PFS) in Gr. IV patients (P = 0.028), and had no effect in Gr. III glioma patients (P = 0.522). Furthermore, the receiver operating characteristic (ROC) curve revealed the critical role of IL8 with an accuracy value of 0.899 for discriminating Gr. IV from Gr. III in TCGA and 0.644 in CGGA. Macrophage (P
- Published
- 2022
5. The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity
- Author
-
Chien-Yu Huang, Po-Li Wei, G. M. Shazzad Hossain Prince, Uyanga Batzorig, Cheng-Chin Lee, Yu-Jia Chang, and Chin-Sheng Hung
- Subjects
Medicine (miscellaneous) ,breast cancer ,thrombomodulin ,estrogen receptor ,progression ,migration ,curcumin ,resistant ,General Biochemistry, Genetics and Molecular Biology - Abstract
Estrogen and estrogen receptors (ER) play a key role in breast cancer progression, which can be treated with endocrine therapy. Nevertheless, resistance to endocrine therapies is developed over time. The tumor expression of thrombomodulin (TM) is correlated with favorable prognosis in several types of cancer. However, this correlation has not yet been confirmed in ER-positive (ER+) breast cancer. This study aims to evaluate the role of TM in ER+ breast cancer. Firstly, we found that lower TM expression correlates to poor overall survival (OS) and relapse-free survival (RFS) rates in ER+ breast cancer patients through Kaplan–Meier survival analysis (p < 0.05). Silencing TM in MCF7 cells (TM-KD) increased cell proliferation, migration, and invasion ability. Additionally, TM-KD MCF7 cells showed higher sensitivity (IC50 15 μM) to the anti-cancer agent curcumin than the scrambled control cells. Conversely, overexpression of TM (TM-over) in T47D cells leads to decreased cell proliferation, migration, and invasion ability. Furthermore, TM-over T47D cells showed more resistance (IC50 > 40 μM) to the curcumin treatment. The PI staining, DAPI, and tunnel assay also confirmed that the curcumin-induced apoptosis in TM-KD MCF7 cells was higher (90.34%) than in the scrambled control cells (48.54%). Finally, the expressions of drug-resistant genes (ABCC1, LRP1, MRP5, and MDR1) were determined by qPCR. We found that the relative mRNA expression levels of ABCC1, LRP1, and MDR1 genes after curcumin treatment were higher in scrambled control cells than in TM-KD cells. In conclusion, our results demonstrated that TM plays a suppressive role in the progression and metastasis of ER+ breast cancer, and it regulates curcumin sensitivity by interfering with ABCC1, LRP1, and MDR1 gene expression.
- Published
- 2023
6. Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of ETV1 and MAPK Pathway in Colorectal Cancer
- Author
-
Po Li Wei, Chien Yu Huang, Uyanga Batzorig, Weu Wang, and Yu Jia Chang
- Subjects
Male ,MAPK/ERK pathway ,Epithelial-Mesenchymal Transition ,Carcinogenesis ,MAP Kinase Signaling System ,Glucose-regulated protein ,proliferation ,p38 mitogen-activated protein kinases ,colorectal cancer ,GRP94 ,metastasis ,medicine.disease_cause ,ETV1 ,Metastasis ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Cell Proliferation ,Gene knockdown ,Membrane Glycoproteins ,biology ,Cell growth ,General Medicine ,medicine.disease ,DNA-Binding Proteins ,Gene Expression Regulation, Neoplastic ,Gene Knockdown Techniques ,Cancer research ,biology.protein ,030211 gastroenterology & hepatology ,Colorectal Neoplasms ,Transcription Factors ,Research Paper - Abstract
Colorectal cancer (CRC) is a worldwide health problem. Glucose-regulated protein 94 (GRP94) is known as an important endoplasmic reticulum-stress response protein that shows correlation with aggressive cancer behavior. However, the role of GRP94 in CRC is still unclear. Our results showed that silencing GRP94 (GRP94-KD) reduced cell proliferation, invasion and migration of CRC cells and suppressed tumorigenesis in the xenograft mouse model. Rescue assay showed that ETV1 overexpression reversed the effect of GRP94 on cell proliferation and migration. In the molecular mechanism, we found that knockdown of GRP94 inhibited the level of MAPK pathway, including ERK/p-ERK, JNK/p-JNK, and p38/p-p38 signals. Cyclooxygenase-2 and epithelial-mesenchymal transformation biomarkers, such as N-cadherin, vimentin, and β-catenin were suppressed in GRP94 knockdown cells. Treatment of specific inhibitors of MAPK pathway showed that ERK/p-ERK, and p38/p-p38 inhibitors significantly influenced ETV1 expression as compared to JNK/p-JNK inhibitor. Our results indicated that silencing GRP94 repressed the ability of EMT process, cancer cell proliferation, metastasis, and CRC tumorigenesis. Therefore, GRP94 may play an important role in CRC by regulating ETV1 and MAPK pathway.
- Published
- 2021
7. Light-Controlled Gap-Type TFT Used for Large-Area Under-Screen Fingerprint Sensor
- Author
-
Che-Yu Chuang, Yu-Jia Chang, Mao-Hsiu Hsu, Ya-Hsiang Tai, Yi-Cheng Yuan, and Cheng-Che Tu
- Subjects
thin film transistor (TFT) ,Pixel ,Computer science ,Transistor ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Integrated circuit ,Fingerprint recognition ,gap-type ,photocurrent ,Signal ,TK1-9971 ,Electronic, Optical and Magnetic Materials ,law.invention ,law ,Thin-film transistor ,Electronic engineering ,OLED ,Electrical engineering. Electronics. Nuclear engineering ,Electrical and Electronic Engineering ,Sensitivity (electronics) ,Fingerprint sensor ,Biotechnology - Abstract
In the fierce market competition of different biometric methods in smartphones, where consumers are pursuing a high screen ratio, optical fingerprint recognition under OLED screen is a well-established approach. However, using thin-film transistor (TFT) technology to make large-area optical sensors generally has the issue of low sensitivity, which will make the signal difficult to be read out. In this paper, we propose to use gap-type TFT with high photosensitivity current and process compatible with display panels as the sensing device to build the sensing array. The pixel circuit can be simplified to structure containing only of two thin-film transistors (TFTs). Using this gap-type TFT sensing array under OLED panel for fingerprint recognition is proven to be effective by the clear images captured with the readout system.
- Published
- 2021
8. Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
- Author
-
Chien Wei Su, Chun-Chao Chang, Jui-Hsiang Tang, Chi-Long Chen, Wei-Yu Kao, Yu Jia Chang, I-Wei Chang, Weu Wang, and Sheng Uei Fang
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Biopsy ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Fibrosis ,Internal medicine ,Nonalcoholic fatty liver disease ,medicine ,Humans ,Prospective Studies ,Stage (cooking) ,Prospective cohort study ,Nutrition and Dietetics ,medicine.diagnostic_test ,Receiver operating characteristic ,business.industry ,medicine.disease ,Obesity, Morbid ,Liver ,Liver biopsy ,Elasticity Imaging Techniques ,Female ,030211 gastroenterology & hepatology ,Surgery ,Transient elastography ,business ,Body mass index - Abstract
The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been reported in 74 to 90% of morbidly obese patients. This study aims to develop a scoring system that predicts significant liver fibrosis in morbidly obese patients. This prospective cohort study involved 123 morbidly obese patients who underwent metabolic surgery at Taipei Medical University Hospital between October 2016 and June 2018. Wedge liver biopsy was performed during surgery, and significant liver fibrosis was defined as a fibrosis score ≧ 2. Ultrasonography and transient elastography were performed prior to surgery to assess the risk factors associated with significant liver fibrosis. Mean patient age was 35.5 years, mean body mass index (BMI) was 40.6 kg/m2, and 87 (70.7%) were female. Fibrosis staging revealed 28 (22.8%) at stage 2, 14 (11.4%) at stage 3, and 2 (1.6%) at stage 4. Patients were then separated into training (n = 73) and validation (n = 50) cohorts. Multivariate analysis revealed a liver stiffness measurement (LSM) > 7 kPa and aspartate aminotransferase/platelet ratio index (APRI) > 0.40 as independent factors associated with significant liver fibrosis among the training cohort. Fibroscan-base score weighted sum of (1 for presence of APRI > 0.40) + (2 for presence of LSM > 7 kPa) yielded the highest area under receiver operating curve (0.854, P = 0.0001; 0.785, P = 0.0002) compared with other non-invasive markers in the training and validation cohorts, respectively. We developed a simple, clinical scoring system incorporating Fibroscan and APRI to predict significant liver fibrosis in morbidly obese patients.
- Published
- 2020
9. Applying the Cyber-Physical Integration Technology on Material Color Discrimination
- Author
-
Wen-Jye Shyr, Fan-Yu Shih, and Yu-Jia Chang
- Published
- 2021
10. A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer
- Author
-
Yu-Tien Chang, Wen-Chiuan Tsai, Wei-Zhi Lin, Chia-Chao Wu, Jyh-Cherng Yu, Vincent S. Tseng, Guo-Shiou Liao, Je-Ming Hu, Huan-Ming Hsu, Yu-Jia Chang, Meng-Chiung Lin, Chi-Ming Chu, and Chien-Yi Yang
- Subjects
Cancer Research ,breast cancer ,Oncology ,MDA-MB-231 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,next-generation sequencing ,prognosis ,immunoglobulin ,triple-negative breast cancer (TNBC) ,RC254-282 - Abstract
BackgroundImmunoglobulin-related genes are associated with the favorable prognosis of triple-negative breast cancer (TNBC) patients. We aimed to analyze the function and prognostic value of immunoglobulin lambda constant 2 (IGLC2) in TNBC patients.MethodsWe knocked down the gene expression of IGLC2 (IGLC2-KD) in MDA-MB-231 cells to evaluate the proliferation, migration, and invasion of tumors via 3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, wound healing, and transwell cell migration assay respectively. Relapse-free survival (RFS) and distant metastasis-free survival (DMFS) analyses were conducted using the KM plotter online tool. The GSE76275 data set was used to analyze the association of IGLC2 and clinical characteristics. A pathway enrichment analysis was conducted using the next-generation sequencing data of wild-type and IGLC2-KD MDA-MB-231 cells.ResultsThe low gene expression of IGLC2 was related to unfavorable RFS, DMFS. The high expression of IGLC2 was exhibited in the basal-like immune-activated (BLIA) TNBC molecular subtype, which was immune-activated and showed excellent response to immune therapy. IGLC2 was positively correlated with programmed death-ligand 1 (PD-L1) as shown by Spearman correlation (r = 0.25, p < 0.0001). IGLC2 had a strong prognostic effect on lymph node-negative TNBC (RFS range: 0.31, q value= 8.2e-05; DMFS = 0.16, q value = 8.2e-05) but had no significance on lymph node-positive ones. The shRNA-mediated silencing of IGLC2 increased the proliferation, migration, and invasion of MDA-MB-231 cells. The results of pathway enrichment analysis showed that IGLC2 is related to the PI3K-Akt signaling pathway, MAPK signaling pathway, and extracellular matrix–receptor interaction. We confirmed that MDA-MB-231 tumor cells expressed IGLC2, subverting the traditional finding of generation by immune cells.ConclusionsIGLC2 linked with the proliferation, migration, and invasion of MDA-MB-231 cells. A high expression of IGLC2 was related to favorable prognosis for TNBC patients. IGLC2 may serve as a biomarker for the identification of TNBC patients who can benefit the most from immune checkpoint blockade treatment.
- Published
- 2021
11. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer
- Author
-
Yu Jia Chang, Ching Wen Chou, Chien Yu Huang, Yu Min Huang, and Chin Sheng Hung
- Subjects
Oncology ,medicine.medical_specialty ,Paclitaxel ,medicine.medical_treatment ,Datasets as Topic ,Down-Regulation ,Triple Negative Breast Neoplasms ,Kaplan-Meier Estimate ,taxane ,Disease-Free Survival ,chemistry.chemical_compound ,Genetic Heterogeneity ,Breast cancer ,Downregulation and upregulation ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Gene Regulatory Networks ,Protein Interaction Maps ,Gene ,Triple-negative breast cancer ,Chemotherapy ,Taxane ,business.industry ,IL18R1 ,bioinformative ,General Medicine ,medicine.disease ,GEO ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,chemistry ,Drug Resistance, Neoplasm ,Neoplasm Recurrence, Local ,business ,TNBC ,Research Paper ,basal-like-TNBC - Abstract
Developing treatment strategies for triple-negative breast cancer (TNBC) has become an important clinical challenge. Currently, taxane-based chemotherapy is one of the standard treatments for TNBC. However, determining the key factor of taxane-resistance is urgently in need for clinical treatment for breast cancer. We used GEO data to generate paclitaxel resistance in two basal-like TNBC cell lines (SUM149 and MDA-MB-468). Seventy-one common upregulated differentially expressed genes (DEGs) and 11 downregulated DEGs were found to be related to paclitaxel resistance. By constructing protein-protein interactions, 28 hub proteins with a degree cutoff criterion of ≥1 were found. Nine hub genes (COL4A6, COL4A5, IL6, PDGFA, LPAR1, FYB, IL20, IL18R1 and INHBA) are involved in important signaling pathways. We found that upregulated PDGFA and downregulated COL4A6 were significantly associated with an insensitive response to neoadjuvant paclitaxel-based therapy. A Kaplan-Meier plot was created to check the prognostic values of 11 hub DEGs in terms of recurrence-free survival. High expressions of PDGFA and LAMB3 were correlated with poor recurrence-free survival, while low levels of FYB, IL18R1, and RASGRP1 indicated poorer relapse-free survival. Our results suggest that PDGFA, COL4A6, LPAR1, FYB, COL4A5, and RASGRP1 might be candidate target genes for taxane-based therapy in basal-like TNBC.
- Published
- 2021
12. Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis
- Author
-
I-Wei Chang, Chi-Long Chen, Chun-Chao Chang, Yu Jia Chang, Jui-Hsiang Tang, Weu Wang, Yuan-Feng Lin, and Wei-Yu Kao
- Subjects
Adult ,Male ,medicine.medical_specialty ,Bariatric Surgery ,030204 cardiovascular system & hematology ,digestive system ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Internal medicine ,Diabetes mellitus ,Nonalcoholic fatty liver disease ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,medicine.diagnostic_test ,business.industry ,Interleukin-2 Receptor alpha Subunit ,nutritional and metabolic diseases ,General Medicine ,Odds ratio ,medicine.disease ,digestive system diseases ,030220 oncology & carcinogenesis ,Liver biopsy ,Biomarker (medicine) ,Female ,Steatosis ,business ,Body mass index ,Biomarkers - Abstract
Background Two recent studies in the adult and pediatric Nonalcoholic Steatohepatitis-Clinical Research Network (NASH-CRN) cohorts have shown that soluble interleukin-2 receptor alpha (IL2RA) levels increased with fibrosis severity. However, no hepatic study has been conducted in Asian morbidly obese patients who underwent bariatric surgery. In this study, we proposed IL2RA as a biomarker for nonalcoholic fatty liver disease (NAFLD) diagnosis and performed immunohistochemistry (IHC) staining of IL2RA. Methods This prospective cohort study enrolled 123 morbidly obese patients who underwent bariatric surgery at Taipei Medical University Hospital from October 2016 to June 2018. During bariatric surgery, all patients underwent a wedge liver biopsy under laparoscopic guidance. The diagnoses of NASH and liver fibrosis were made histologically. In IHC of IL2RA, the number of lymphocytes with IL2RA immunoreactivity was counted in five high-power fields (×400, total: 1.19 mm2). Results Among the 123 patients, the mean age was 35.5 years, mean body mass index (BMI) was 40.6 kg/m2, 87 (70.7%) were female, 25 (20.7%) had diabetes mellitus, and 57 (46.3%; 11 with non-NAFLD and 46 with steatosis) and 66 (53.7%) were included in the non-NASH and NASH groups, respectively. The NASH group had higher IHC of IL2RA than the non-NASH group. In multivariate analysis, IHC of IL2RA (odds ratio, 1.025; 95% confidence interval, 1.006-1.045; p = 0.011) and alanine aminotransferase (ALT; odds ratio, 1.045; 95% confidence interval, 1.018-1.073; p = 0.001) were the independent factors associated with NASH. The area under the receiver operating curve of IL2RA IHC for NASH was 0.627 at the cutoff value of 82 (p = 0.0113). Conclusion IL2RA is significantly associated with NASH in morbidly obese patients and would be a useful biomarker for NASH diagnosis.
- Published
- 2020
13. Application of Cyber-Physical System Technology on Material Color Discrimination
- Author
-
Wen-Jye Shyr, Hou-Chueh Juan, Chih-Yu Tsai, and Yu-Jia Chang
- Subjects
Computer Networks and Communications ,Hardware and Architecture ,Control and Systems Engineering ,Signal Processing ,Electrical and Electronic Engineering ,cyber factory ,cyber-physical integration ,cyber-physical system (CPS) ,human machine interface (HMI) ,programmable logic controller (PLC) - Abstract
With the innovative advance in science and technology, manufacturing production methods have made considerable progress. However, before the production process is actually implemented, it is important to examine whether the design can meet the actual need. By applying cyber-physical system technology to test the production process, the development problems of the actual construction can be avoided. Based on the existing components, this study incorporated the cyber-physical system via innovative integration. In addition to the human–machine interface, this was employed as the operating spindle to integrate the material color identification system of the physical organization. This study also adopted the automated virtual factory constructed by the simulation software of Factory IO with an aim to achieve the technical application.
- Published
- 2022
14. Novel Low-Voltage Electro-Ejaculation Approach for Sperm Collection from Zoo Captive Lanyu Miniature Pigs (
- Author
-
Yu-Hsin, Chen, Jane-Fang, Yu, Yu-Jia, Chang, Shih-Chien, Chin, Lih-Chiann, Wang, Hsiu-Lien, Lin, and Pei-Shiue, Tsai
- Subjects
zoo ,semen collection ,Article ,wild boar ,electro-ejaculation - Abstract
Simple Summary Preservation of genetic materials from zoo animals is important to improve genetic diversity and to prolong the existence of endangered species for future retrieval. Methods to acquire sperm samples from the animals can be achieved by hand penile massage or by rectal stimulation with electric probe. Traditional electrical stimulation applies relatively high voltage to achieve sufficient stimulation; however, this method causes stress and discomfort to the animal. In the current study, we establish a low-voltage base electrical stimulation approach to obtain semen sample from zoo captive lanyu miniature pigs. We showed that, with our method, a sufficient amount of semen ejaculates with good sperm quality can be obtained. Future improvement on cryopreservation protocol will allow better preservation outcome for successful fertilization in this species. Abstract Semen collection can be achieved via hand penile massage or rectal stimulation using electro-ejaculation methods. Traditional electro-ejaculation procedure applied relatively high voltage of 3–15 volts with a maximum current of 900 mA. However, these manipulations often result in great stress and discomforts in animals. In this study, we showed low-voltage electro-ejaculation procedure using 2–3 volts with a maximum current of 500 mA can efficiently stimulated ejaculations in zoo captive lanyu miniature pigs with a high success rate of 81.3% (13/16). Besides normal semen properties (semen volume, pH, sperm concentration), we demonstrated that low-voltage electro-ejaculation caused less stress in the animals, and sperm cells obtained via low-voltage electro-ejaculation exhibit low abnormality (10.3%), high viability (84.3%), motility (75.7%), progressive motility (63.7%), and acrosome integrity (88%). However, cryopreservation protocol used in the current study requires further optimization, as sperm mitochondrial function was partially compromised during freezing procedures. Taken together, we demonstrated in this study that a low-voltage electro-ejaculation approach can be used to obtain quality sperm cells from zoo captive lanyu miniature pig with less physical stress during electro-ejaculation procedure.
- Published
- 2020
15. A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity
- Author
-
Chien Yu Huang, Chun Ming Shih, Tsorng Harn Fong, Kuo Hsien Wang, Ai Wei Lee, Yu Jia Chang, Po Li Wei, Chun Yao Huang, and Jun Liang Pan
- Subjects
Keratinocytes ,Male ,0301 basic medicine ,animal structures ,Nitric Oxide Synthase Type III ,Dipeptidyl Peptidase 4 ,030209 endocrinology & metabolism ,Dermatology ,Dipeptidyl peptidase-4 inhibitor ,Pharmacology ,Biochemistry ,Cell Line ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Re-Epithelialization ,Glucagon-Like Peptide 1 ,Diabetes mellitus ,medicine ,Animals ,Phosphorylation ,Molecular Biology ,Healing wounds ,Dipeptidyl peptidase-4 ,Cell Proliferation ,Skin ,Dipeptidyl-Peptidase IV Inhibitors ,Adiponectin ,business.industry ,Sitagliptin Phosphate ,Cell Differentiation ,medicine.disease ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Blood-Brain Barrier ,Regional Blood Flow ,Sitagliptin ,Wounds and Injuries ,Wound healing ,Keratinocyte ,business ,medicine.drug - Abstract
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a well-known and novel class of oral antihyperglycaemic drugs. DPP-4 inhibition facilitates ulcer healing in patients with diabetes. However, the actual mechanisms, which are independent of lower blood glucose levels, are still unknown. Therefore, the aim of this study was to analyse the effect of the DPP-4 inhibitor sitagliptin on wound healing through a glucose-independent pathway. In this study, DPP-4 inhibitors facilitate keratinocyte differentiation and the proliferation, increase blood flow in the cutaneous of wounds in healthy C57BL/6 mice. Additionally, the administration of the DPP-4 inhibitor ameliorates wound healing and enhances adiponectin expression in healthy C57BL/6 mice. Taken together, our results reveal a protective role for the DPP-4 inhibitor sitagliptin in wound healing by regulating adiponectin and phospho-eNOS levels in keratinocytes. Based on these results, the DPP-4 inhibitor may have therapeutic potential for healing wounds through a diabetes-independent mechanism.
- Published
- 2018
16. A common regulatory variant in <scp>SLC</scp> 35B4 influences the recurrence and survival of prostate cancer
- Author
-
Bo-Ying Bao, Yu Jia Chang, Te-Ling Lu, Eric Yi Hsiu Huang, Chao-Yuan Huang, Shu Pin Huang, Ta-Yuan Chang, Victor C. Lin, Chia Cheng Yu, and Hsin Ling Yin
- Subjects
Male ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Candidate gene ,medicine.medical_treatment ,Taiwan ,Single-nucleotide polymorphism ,Polymorphism, Single Nucleotide ,Cohort Studies ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,DU145 ,Internal medicine ,medicine ,Humans ,regulatory variant ,SLC35B4 ,Gene ,Aged ,Genetic association ,Prostatectomy ,business.industry ,Prostatic Neoplasms ,Original Articles ,Cell Biology ,Middle Aged ,prostate cancer ,medicine.disease ,multi‐stage association study ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Tissue Array Analysis ,030220 oncology & carcinogenesis ,Localized disease ,Nucleotide Transport Proteins ,Molecular Medicine ,Original Article ,prognosis ,Neoplasm Recurrence, Local ,business - Abstract
Single nucleotide polymorphisms (SNPs) within the regulatory elements of a gene can alter gene expression, making these SNPs of prime importance for candidate gene association studies. We aimed to determine whether such regulatory variants are associated with clinical outcomes in three cohorts of patients with prostate cancer. We used RegulomeDB to identify potential regulatory variants based on in silico predictions and reviewed genome‐wide experimental findings. Overall, 131 putative regulatory SNPs with the highest confidence score on predicted functionality were investigated in two independent localized prostate cancer cohorts totalling 458 patients who underwent radical prostatectomy. The statistically significant SNPs identified in these two cohorts were then tested in an additional cohort of 504 patients with advanced prostate cancer. We identified one regulatory SNPs, rs1646724, that are consistently associated with increased risk of recurrence in localized disease (P = .003) and mortality in patients with advanced prostate cancer (P = .032) after adjusting for known clinicopathological factors. Further investigation revealed that rs1646724 may affect expression of SLC35B4, which encodes a glycosyltransferase, and that down‐regulation of SLC35B4 by transfecting short hairpin RNA in DU145 human prostate cancer cell suppressed proliferation, migration and invasion. Furthermore, we found increased SLC35B4 expression correlated with more aggressive forms of prostate cancer and poor patient prognosis. Our study provides robust evidence that regulatory genetic variants can affect clinical outcomes.
- Published
- 2018
17. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis
- Author
-
Chien Yu Huang, Chia Hwa Lee, Ming Te Huang, Po Li Wei, Yu Jia Chang, Chih Hsiung Wu, and Chao Chiang Tu
- Subjects
0301 basic medicine ,Glucose-regulated protein ,GRP94 ,Mitochondrion ,Biology ,Metastasis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Gene silencing ,Protein kinase B ,Cell growth ,ESCC ,Cancer ,COX-2 ,medicine.disease ,VEGF ,Vascular endothelial growth factor ,030104 developmental biology ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Research Paper - Abstract
Esophageal cancer is a worldwide health problem with a very poor prognosis. Therefore, new diagnostic biomarkers or therapeutic strategies for identifying and managing esophageal squamous cell carcinoma (ESCC) are urgently needed. Glucose-regulated protein 94 (GRP94) is one of major endoplasmic reticulum-stress response proteins that plays a key role in cancer progression and therapeutic responses. However, the role of GRP94 in ESCC progression and metastasis remains unclear. The tissue array results indicated that higher GRP94 expression levels were associated with lower overall survival and higher lympho-node metastasis. Silencing GRP94 (GRP94-KD) reduced cell proliferation, migration and invasion in ESCC cells. In a xenotransplantation assay, silencing GRP94 reduced cell proliferation in the zebrafish embryo. Transmission electron microscopy revealed impaired mitochondria in GRP94-KD cells, which exhibited reduced basal respiration, spare respiratory capacity and ATP production and increased oxidative damage compared with scrambled control cells. Regarding the molecular mechanism underlying the effects of GRP94 knockdown, we found that silencing GRP94 may reduce the level of NF-kB, c-Jun, p38, IL-6, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) as well as activation of AKT and ERK. In conclusion, our results indicate that silencing GRP94 in ESCC cells suppressed cancer growth and the metastatic potential via mitochondrial functions and NF-kB/COX-2/VEGF in ESCC cells.
- Published
- 2018
18. Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer
- Author
-
Yu Jia Chang, Yu Fang Huang, Chien Hsing Lin, Wei Yu Chen, Shih-Feng Tsai, Shih Ching Chang, Shih Feng Chiu, Ruo Kai Lin, and Wan Yu Hung
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Gene knockdown ,Colorectal cancer ,business.industry ,medicine.disease ,Reverse transcription polymerase chain reaction ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,CpG site ,030220 oncology & carcinogenesis ,Internal medicine ,DNA methylation ,medicine ,Immunohistochemistry ,Epigenetics ,business ,Gene - Abstract
Aberrant hypermethylation of CpG islands in tumor suppressor genes (TSGs) contributes to colorectal tumorigenesis. To identify new colorectal cancer (CRC) screening marker, we investigated DNA methylation alterations in novel TSGs. Using HumanMethylation450 BeadChip arrays, CpG regions in BEND5 were the most highly methylated among all genomic regions in 26 colorectal tumors compared to paired non-neoplastic tissues from a Taiwan cohort. Therefore, BEND5 was selected for further analysis. Quantitative methylation-specific real-time PCR revealed that 86.7% (117/135) of CRC patients exhibited hypermethylated BEND5. Real-time reverse transcription PCR identified that BEND5 mRNA expression was downregulated in 68% (32/47) of the analyzed samples. BEND5 hypermethylation was associated with poor overall survival (OS) in Taiwan patients with early-stage CRC (P = 0.037). In a CRC tissue set from South Korea, OS was higher in patients with high BEND5 protein expression than in those with low BEND5 protein expression (P = 0.037) by using immunohistochemistry assays. Consistently, BEND5 hypermethylation was associated with poor OS in patients with early-stage CRC in The Cancer Genome Atlas (TCGA) data set (P = 0.003). Multivariate Cox proportional hazards regression analysis further supported that hypermethylation of BEND5 genes was significantly associated with OS in Taiwan and TCGA CRC patients (P = 0.023 and 0.033, respectively). Finally, the cell model assay with transient transfection of BEND5 or si-BEND5 knockdown indicated that BEND5 inhibited cancer cell proliferation. In conclusion, epigenetic alteration in the candidate TSG BEND5 contributes to colorectal cancer development and is a prognostic marker of CRC.
- Published
- 2017
19. IGFBP2 plays an important role in heat shock protein 27-mediated cancer progression and metastasis
- Author
-
Ming Te Huang, Po Li Wei, Chia Hwa Lee, Chien Yu Huang, Wei Yu Chen, Chin Sheng Hung, and Yu Jia Chang
- Subjects
0301 basic medicine ,Gerontology ,Oncology ,endocrine system ,Poor prognosis ,medicine.medical_specialty ,animal structures ,Medical laboratory ,urologic and male genital diseases ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Cancer biology ,HCC ,Hsp27 ,Therapeutic strategy ,business.industry ,medicine.disease ,University hospital ,030104 developmental biology ,030220 oncology & carcinogenesis ,embryonic structures ,IGFBP2 ,business ,Medical science ,Research Paper - Abstract
// Chin-Sheng Hung 1, 2, 3, * , Chien-Yu Huang 2, 4, * , Chia-Hwa Lee 5 , Wei-Yu Chen 6, 7 , Ming-Te Huang 2, 4 , Po-Li Wei 2, 3, 8, 9, 10, 11 and Yu-Jia Chang 1, 2, 3, 11 1 Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC 2 Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC 3 Division of General Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei, Taiwan, ROC 4 Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, ROC 5 School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, ROC 6 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC 7 Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC 8 Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan, ROC 9 Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan, ROC 10 Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan, ROC 11 Cancer Research Center, Taipei Medical University Hospital, Taipei, Taiwan, ROC * These authors contributed equally to this work Correspondence to: Po-Li Wei, email: poliwei@tmu.edu.tw Yu-Jia Chang, email: r5424012@tmu.edu.tw Keywords: HCC, Hsp27, IGFBP2 Received: February 08, 2017 Accepted: June 18, 2017 Published: July 05, 2017 ABSTRACT Heat shock protein 27 (Hsp27) is a key chaperone that interacts with over 200 client proteins. The expression of Hsp27 might be correlated with poor outcome in many types of cancer. Previous study indicated that Hsp27 might be an important biomarker in hepatocellular carcinoma (HCC). However, the detailed mechanism is less well understood. The shRNA-mediated silencing of Hsp27 decreased the proliferation, migration and invasion of HCC cells. In a xenograft model, the silencing of Hsp27 reduced tumor progression. We revealed that the silencing of Hsp27 led to a reduction in insulin-like growth factor binding protein 2 (IGFBP2), which might mediate proliferation and metastasis through vimentin, snail and beta-catenin. The overexpression of IGFBP2 reversed the reductions in cell growth, migration and invasion. The tissue array results showed that HCC patients with high Hsp27 expression exhibited poor prognosis and increased metastasis. The Hsp27 expression was highly correlated with IGFPB2 in CRC specimen. ChIP and luciferase assays showed that Hsp27 does not directly bind the IGFBP2 promoter region to regulate the transcription of IGFBP2. In conclusion, our study demonstrated that Hsp27 is a key mediator of HCC progression and metastasis and that Hsp27 might regulate proliferation and metastasis through IGFBP2. This pathway might provide a new direction for the development of a novel therapeutic strategy for HCC.
- Published
- 2017
20. Contrast-Enhanced Ultrasound and Computed Tomography Assessment of Hepatocellular Carcinoma after Transcatheter Arterial Chemo-Embolization: A Systematic Review
- Author
-
Chun Chao Chang, Ming Te Huang, Ray Jade Chen, Hung Yi Chiou, Cheng Jeng Tai, Li Jen Kuo, Yeu Ching Shi, Po Lei Wei, Chen Jei Tai, Chih Hsiung Wu, and Yu Jia Chang
- Subjects
Adult ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Radiofrequency ablation ,medicine.medical_treatment ,Contrast Media ,030218 nuclear medicine & medical imaging ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,law ,medicine ,Carcinoma ,Humans ,Embolization ,Chemoembolization, Therapeutic ,Transcatheter arterial chemoembolization ,Aged ,Ultrasonography ,business.industry ,Liver Neoplasms ,Gastroenterology ,Reproducibility of Results ,Middle Aged ,medicine.disease ,Treatment Outcome ,Response Evaluation Criteria in Solid Tumors ,030220 oncology & carcinogenesis ,Predictive value of tests ,Hepatocellular carcinoma ,Female ,Radiology ,Tomography, X-Ray Computed ,business ,Contrast-enhanced ultrasound - Abstract
Background & Aims: Contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT) are used to assess the response of hepatocellular carcinoma after transarterial chemoembolization. Our aim was to perform a systematic review to compare CEUS and CECT for therapeutic response assessment to transarterial chemoembolization in the treatment of hepatocellular carcinoma. Method: PubMed, Embase, and the Cochrane Library databases were searched from inception until January 1, 2016. Participants: patients with hepatocellular carcinoma. Intervention: transarterial chemoembolization and CECT vs CEUS. Results. Sixteen studies were included in the systematic review. The total number of patients was 858 and the mean patient age ranged from 42 to 73 years. The mean tumor size ranged from 1.0 cm to 4.3 cm. The sensitivity and specificity of CEUS ranged from 46% to 100% and 65% to 100%, respectively, and that of CECT ranged from 34% to 87% and 92% to 100%, respectively. The accuracy of CEUS ranged from 72.6% to 100% and that of CECT from 61% to 94%. Marked heterogeneity was present among the studies. Conclusion: CEUS is comparable with CECT for the therapeutic response assessment after transarterial chemoembolization. Abbreviations: CECT: Contrast-enhanced CT; CEUS: Contrast-enhanced Ultrasound; CT: Computed Tomography; HCC: Hepatocellular Carcinoma; MDCT: Multidetector row CT; MRI: Magnetic Resonance Imaging; mRECIST: modified Response Evaluation Criteria in Solid Tumors; NPV: Negative Predictive Value; PPV: Positive Predictive Value; QUADAS-2: Quality Assessment of Diagnostic Accuracy Studies; RFA: Radiofrequency Ablation; TACE: Transcatheter Arterial Chemoembolization.
- Published
- 2016
21. Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
- Author
-
Chia-Cheng Yu, Victor C. Lin, Te-Ling Lu, Yu Jia Chang, Lih-Chyang Chen, Chao-Yuan Huang, Bo-Ying Bao, Cheng-Hsueh Lee, I-Ling Lin, Chih-Yung Chiou, Shu-Pin Huang, and Ta-Yuan Chang
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Single-nucleotide polymorphism ,NPAS2 ,lcsh:RC254-282 ,Germline ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Polymorphism (computer science) ,Internal medicine ,Genetics ,Medicine ,Circadian rhythm ,lcsh:QH573-671 ,Allele ,Progression ,lcsh:Cytology ,business.industry ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Single nucleotide polymorphism ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,Primary Research ,business - Abstract
Background To determine the association between circadian pathway genetic variants and the risk of prostate cancer progression. Methods We systematically evaluated 79 germline variants in nine circadian pathway genes in a cohort of 458 patients with localized prostate cancer as the discovery phase. We then replicated the significant findings in another cohort of 324 men with more advanced disease. The association of each variant with prostate cancer progression was evaluated by a log-rank test and Cox regression. Results A single nucleotide polymorphism of the neuronal PAS domain protein 2 (NPAS2) gene (rs6542993 A>T) was found to be associated with a significantly higher risk of disease progression in both localized (P = 0.001) and advanced (P = 0.039) prostate cancer cases. In silico analysis revealed decreased expression levels of NPAS2 in carriers of the T allele of rs6542993 compared with those carrying the A allele. Consistently, downregulation of NPAS2 expression was associated with more aggressive prostate cancer and poor progression-free survival (log-rank P = 0.002). Conclusions The NPAS2 rs6542993 polymorphism may be a promising biomarker, and may shed light on the pathways that govern prostate cancer progression. Electronic supplementary material The online version of this article (10.1186/s12935-019-0811-4) contains supplementary material, which is available to authorized users.
- Published
- 2019
22. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer
- Author
-
Chang Lin Hsieh, Hon Ping Ma, Yu Jia Chang, Ruo Kai Lin, Yuan Soon Ho, Wan Yu Hung, Chih-Ming Su, and Wei Jan Huang
- Subjects
0301 basic medicine ,Breast Neoplasms ,medicine.disease_cause ,Histone Deacetylases ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Downregulation and upregulation ,Cell Movement ,Cell Line, Tumor ,medicine ,Humans ,RNA, Messenger ,Enzyme Inhibitors ,RNA, Small Interfering ,General Pharmacology, Toxicology and Pharmaceutics ,skin and connective tissue diseases ,Wound Healing ,Gene knockdown ,biology ,HDAC8 ,Cell migration ,General Medicine ,Prognosis ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Repressor Proteins ,030104 developmental biology ,Histone ,Tumor progression ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Female ,Carcinogenesis ,Signal Transduction - Abstract
Aims Alterations in histone proteins can lead to breast tumorigenesis. Selective histone deacetylase 8 (HDAC8) inhibitors with fewer adverse effects have been developed. A more comprehensive study of alterations and its mechanisms in HDAC8 is required. In this study, we investigated mechanisms of dysregulation of HDAC8 expression and its biological role and pathways in breast cancer. Main methods Alterations in HDAC8 were analyzed in Taiwanese breast cancer patients; and in tissue samples from The Cancer Genome Atlas (TCGA) data set that were derived from Western countries. Knockdown by si-HDAC8, treatment with the HDAC8-specific inhibitor PCI-34051, SRB assays, wound healing, Transwell migration assays, Illumina BeadArray™ arrays and Ingenuity Pathway Analysis (IPA) were performed in breast cancer cells. Key findings HDAC8 mRNA expression was upregulated in paired breast cancer tissue from Taiwanese patients and in paired breast cancer tissues from the TCGA data set. Hypomethylation of promoter regions was significantly correlated with HDAC8 mRNA overexpression in 588 breast cancer patients from the TCGA data set and was associated with poor prognosis in early-stage breast cancer. HDAC8 mRNA overexpression was associated with late stages and tumor progression. Wound healing and Transwell migration assays revealed that knockdown by si-HDAC8 or PCI-34051 treatment significantly inhibited breast cancer cell migration. Knockdown by si-HDAC8, Illumina BeadArray™ arrays and IPA found that ID3 and PTP4A2 pathways were regulated by HDAC8 in cancer cell migration. Significance Hypomethylation of the HDAC8 promoter is correlated with HDAC8 overexpression and breast cancer progression and is a potential prognosis marker and drug target.
- Published
- 2016
23. Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts
- Author
-
Ming Te Huang, Po Lei Wei, Ray Jade Chen, Hung Yi Chiou, Chen Jei Tai, Chien Kai Wang, Chun Chao Chang, Chih Hsiung Wu, Yu Jia Chang, Chang Jer Wu, Li Jen Kuo, Hang Wang, and Cheng Jeng Tai
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Bevacizumab ,medicine.medical_treatment ,Cetuximab ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Antineoplastic Agents, Immunological ,0302 clinical medicine ,Carcinoembryonic antigen ,Drug Therapy ,Pancreatic tumor ,Internal medicine ,Pancreatic cancer ,medicine ,Animals ,Humans ,Cisplatin ,Mice, Inbred BALB C ,Chemotherapy ,biology ,business.industry ,General Medicine ,medicine.disease ,Gemcitabine ,Tumor Burden ,Pancreatic Neoplasms ,Disease Models, Animal ,Treatment Outcome ,030104 developmental biology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Heterografts ,Drug Therapy, Combination ,Female ,business ,medicine.drug - Abstract
Pancreatic cancer remains the fourth leading cause of cancer-related death in the USA with a 5-year survival rate of 5 %. The effects of epidermal growth factor receptor and vascular endothelial growth factor A blockade with chemotherapy on pancreatic tumor growth were examined. Mice bearing human PANC-1 cell xenografts were divided into three groups: T-CR (gemcitabine, cisplatin, and 5-fluorouracil), T-TR (cetuximab, bevacizumab, gemcitabine, cisplatin, and 5-fluorouracil), and vehicle control (T). The therapies were administered via intraperitoneal injections every 4 days for seven cycles from 7 weeks after cancer cell implantation. Mice treated with T-TR had significant reductions in tumor weight as compared to the control group (p
- Published
- 2016
24. Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment
- Author
-
Po Li Wei, Chao Chiang Tu, Chin Sheng Hung, Yu Jia Chang, Wan Li Cheng, and Chien Yu Huang
- Subjects
0301 basic medicine ,Small interfering RNA ,alpha7 Nicotinic Acetylcholine Receptor ,Blotting, Western ,Apoptosis ,Adenocarcinoma ,Biology ,Pharmacology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Stomach Neoplasms ,Annexin ,Tumor Cells, Cultured ,medicine ,Humans ,Propidium iodide ,RNA, Small Interfering ,Cell Proliferation ,Gene knockdown ,Cell Cycle ,Ixabepilone ,Cancer ,General Medicine ,Flow Cytometry ,medicine.disease ,Tubulin Modulators ,030104 developmental biology ,chemistry ,Drug Resistance, Neoplasm ,Epothilones ,030220 oncology & carcinogenesis ,Cancer cell ,sense organs - Abstract
Gastric cancer is an important health issue worldwide. Currently, improving the therapeutic efficacy of chemotherapy drugs is an important goal of cancer research. Alpha-7 nicotine acetylcholine receptor (A7-nAChR) is the key molecule that mediates gastric cancer progression, metastasis, and therapy responses; however, the role of A7-nAChR in the therapeutic efficacy of ixabepilone remains unclear. A7-nAChR expression was silenced by small interfering RNA (siRNA) technology. The cytotoxicity of ixabepilone was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and ixabepilone-induced apoptosis was analyzed by flow cytometry and annexin V/propidium iodide (PI) apoptotic assay. The expression patterns of anti-apoptotic proteins (AKT, phospho-AKT, Mcl-1, and Bcl-2) and pro-apoptotic proteins (Bad and Bax) were determined by western blot. Our study found that A7-nAChR knockdown (A7-nAChR-KD) AGS cells were more sensitive to ixabepilone administration than scrambled control AGS cells. We found that A7-nAChR knockdown enhanced ixabepilone-induced cell death as evidenced by the increased number of annexin V-positive (apoptotic) cells. After scrambled control and A7-nAChR-KD cells were treated with ixabepilone, we found that pAKT and AKT levels were significantly reduced in both groups of cells. The levels of Bcl-2 and the anti-apoptotic Mcl-1 isoform increased dramatically after ixabepilone treatment in scrambled control cells but not in A7-nAChR-KD cells. Bad and Bax levels did not change between the treatment group and vehicle group in both A7-nAChR-KD and scrambled control cells, whereas cleaved PARP levels dramatically increased in ixabepilone-treated A7-nAChR-KD cells. Our results demonstrated that knockdown of A7-nAChR enhanced the sensitivity of gastric cancer cells to ixabepilone administration. Thus, the A7-nAChR expression level in patients with gastric cancer may be a good indicator of ixabepilone sensitivity.
- Published
- 2016
25. Clinical diagnosis of colorectal cancer using electrospun triple-blend fibrous mat-based capture assay of circulating tumor cells
- Author
-
Yu Jia Chang, Po-Li Wei, Ai-Wei Lee, Jem-Kun Chen, and Hsien Chuan Tseng
- Subjects
Pathology ,medicine.medical_specialty ,Materials science ,biology ,Colorectal cancer ,Biomedical Engineering ,02 engineering and technology ,General Chemistry ,General Medicine ,Stage ii ,010402 general chemistry ,021001 nanoscience & nanotechnology ,medicine.disease ,01 natural sciences ,In vitro ,Stage I colorectal cancer ,0104 chemical sciences ,Sample volume ,Circulating tumor cell ,Clinical diagnosis ,medicine ,biology.protein ,General Materials Science ,Antibody ,0210 nano-technology - Abstract
Conventional in vitro circulating tumor cell (CTC) detection methods are always limited by the blood sample volume because of the extremely low abundance of CTCs among the large number of hematologic cells. The aim of this study was to overcome this limitation by designing and constructing an in vitro CTC capture assay. We blended poly(sulfobetaine methacrylate) (PSBMA) and poly(acrylic acid) (PAA) into nylon-6 through electrospinning to generate a fibrous mat-based capture assay of CTCs. The contents of nylon-6, PSBMA, and PAA in the electrospun triple-blend fibrous mats (ETBFMs) were optimized to avoid degradation and to balance between the non-biofouling behavior and the antibody immobilizing efficiency. In addition, we examined the capture ability of CTCs for clinical diagnoses of colorectal cancer, in comparison with the results identified through pathological analyses of biopsies from colonoscopies. For nine individuals with stage II, III, and IV colorectal cancer, our CTC detection with ETBFMs provided complete positive expression. Two of four individuals were diagnosed to possess stage I colorectal cancer. Two of seven individuals without colorectal tumor, as identified through pathological analyses of biopsies, exhibited positive expression of CTCs. These positive results suggest that such ETBFMs are promising materials for in vitro CTC capture assays.
- Published
- 2016
26. Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma
- Author
-
Cheng-Jeng Tai, Chien Yu Huang, Ming Te Hunag, Uyanga Batzorig, Wan Li Cheng, Yu Jia Chang, and Po-Li Wei
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Glucose-regulated protein ,Blotting, Western ,Cell ,Metastasis ,Small hairpin RNA ,03 medical and health sciences ,0302 clinical medicine ,Cell Movement ,Cell Line, Tumor ,Internal medicine ,medicine ,Humans ,Gene silencing ,HSP70 Heat-Shock Proteins ,Neoplasm Invasiveness ,Gene Silencing ,RNA, Small Interfering ,Wound Healing ,Gene knockdown ,biology ,Liver Neoplasms ,JNK Mitogen-Activated Protein Kinases ,Membrane Proteins ,Cancer ,Cell migration ,General Medicine ,medicine.disease ,digestive system diseases ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,medicine.anatomical_structure ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Cell Migration Assays ,Chaperonin Containing TCP-1 - Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide. Cancer metastasis is a major obstacle in clinical cancer therapy. The mechanisms underlying the metastasis of HCC remain unclear. Glucose-regulated protein 94 (GRP94) is a key protein involved in mediating cancer progression, and it is highly expressed in HCC specimens. However, the role of GRP94 in cancer metastasis is unclear. A specific short hairpin RNA (shRNA) was employed to knock down GRP94 gene expression in HCC cell lines. Wound-healing migration, transwell migration, and invasion assays were performed to determine the migration and invasive ability of HCC cells. We demonstrated that silencing GRP94 inhibited HCC cell wound healing, migration, and invasion. Furthermore, our findings indicated that GRP94 knockdown might attenuate HCC cell metastasis by inhibiting CCT8/c-Jun/EMT signaling. Our study indicated that silencing GRP94 significantly reduced the migration and invasion abilities of HCC cells. Moreover, depleting GRP94 inhibited cell migration and invasion by downregulating CCT8/c-Jun signaling. Thus, our data suggest that the GRP94/CCT8/c-Jun/EMT signaling cascade might be a new therapeutic target for HCC.
- Published
- 2015
27. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma
- Author
-
Uyanga Batzorig, Chien Yu Huang, Po Li Wei, Wei Yu Chen, Ming Te Huang, Yu Jia Chang, and Wan Li Cheng
- Subjects
0301 basic medicine ,Carcinoma, Hepatocellular ,Nitric Oxide Synthase Type III ,Carcinogenesis ,AMP-Activated Protein Kinases ,Bioinformatics ,medicine.disease_cause ,Small hairpin RNA ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Enos ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Gene silencing ,Protein kinase B ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Membrane Glycoproteins ,biology ,Liver Neoplasms ,Cancer ,General Medicine ,biology.organism_classification ,medicine.disease ,Xenograft Model Antitumor Assays ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Tumor progression ,030220 oncology & carcinogenesis ,Disease Progression ,Cancer research ,Proto-Oncogene Proteins c-akt - Abstract
Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.
- Published
- 2015
28. Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer
- Author
-
Ming Te Huang, Cheng Jeng Tai, Sheng Dean Luo, Feng Yen Lin, Batzorig Uyanga, Chien Yu Huang, and Yu Jia Chang
- Subjects
Male ,0301 basic medicine ,Oncology ,Antimetabolites, Antineoplastic ,medicine.medical_specialty ,Myeloid ,Cell ,Apoptosis ,Deoxycytidine ,Androgen deprivation therapy ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,DU145 ,Cell Line, Tumor ,Internal medicine ,medicine ,Humans ,Serpins ,business.industry ,Maspin ,General Medicine ,medicine.disease ,Gemcitabine ,Prostatic Neoplasms, Castration-Resistant ,030104 developmental biology ,medicine.anatomical_structure ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Cancer research ,business ,Signal Transduction ,medicine.drug - Abstract
Androgen deprivation therapy has constituted the main treatment for prostate cancer; however, tumors ultimately progress to hormone-independent prostate cancer (HIPC), and suitable therapeutic strategies for HIPC are not available. Maspin, which is also known as mammary serine protease inhibitor, has been suggested to be a valuable focus for targeted cancer therapy. Specifically, maspin has been shown to be upregulated after androgen ablation therapy. Gemcitabine is used as a first-line therapy for metastatic castration-resistant prostate cancer, but its disease control rate is low. Furthermore, the role of maspin in the therapeutic efficacy of gemcitabine for HIPC remains unclear. The expression levels of maspin in PC-3 and DU145 cells were determined by real-time PCR and Western blotting. Furthermore, the expression of maspin was silenced using shRNA technology to generate maspin-KD cells. The cytotoxicity of gemcitabine to prostate cancer cells was assessed using 3-[4,5-dimethylthiazol-2-yl]-3,5-diphenyl tetrazolium bromide (MTT) assays, whereas flow cytometry analyses and annexin V-propidium iodide (PI) apoptosis assays were used to assess the ability of gemcitabine to induce apoptosis in maspin-KD and control cells. Additionally, the expression patterns of anti-apoptosis proteins (myeloid cell leukemia 1 (Mcl-1) and B cell lymphoma 2 (Bcl-2)) and pro-apoptosis proteins (Bcl-2-associated death promoter (Bad) and Bcl-2-associated X protein (Bax)) were determined by Western blotting. In this study, PC-3 cells were more resistant to gemcitabine administration than DU145 cells, which correlated with the higher expression levels of maspin observed in PC-3 cells. Furthermore, maspin knockdown enhanced gemcitabine-induced cell death, as evidenced by the increased number of apoptotic cells. Gemcitabine treatment upregulated the levels of anti-apoptosis proteins (Mcl-2 and Bcl-2) in both scrambled control and maspin-KD cells; however, the fold changes in Mcl-1 and Bcl-2 expression were larger in gemcitabine-treated scrambled control cells than in maspin-KD cells. Finally, our findings indicate for the first time that maspin may mediate the therapeutic efficacy of gemcitabine in HIPC. Our results demonstrate that maspin knockdown enhanced the sensitivity of androgen-independent prostate cancer cells to gemcitabine. Therefore, combining gemcitabine with a drug that targets maspin might constitute a valuable strategy for prostate cancer treatment.
- Published
- 2015
29. Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential
- Author
-
Hsu Wei Fang, Chen Ying Su, Yu Jia Chang, Ping Chuan Kan, and Chin Sung Chien
- Subjects
0301 basic medicine ,Cancer Research ,Curcumin ,Combination therapy ,Cell Survival ,medicine.disease_cause ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Western blot ,Annexin ,Cell Line, Tumor ,Neoplasms ,medicine ,Humans ,Cell Proliferation ,medicine.diagnostic_test ,Dichloroacetic Acid ,Drug Synergism ,General Medicine ,Cell cycle ,Mitochondria ,Oxidative Stress ,030104 developmental biology ,Oncology ,chemistry ,Apoptosis ,030220 oncology & carcinogenesis ,Toxicity ,Cancer research ,Oxidative stress - Abstract
Background/aim Dichloroacetate (DCA) and curcumin have been shown to be potent drug candidates in cancer therapy. Our study aimed to investigate the combined effects of DCA and essential oil-blended curcumin (ECUR) using the hepatoma Huh-7 cell model. Materials and methods Muse™ Cell Cycle assay, Muse™ Annexin V & Dead Cell assay, Muse™ Oxidative Stress assay, and western blot analysis were applied to explore the underlying mechanisms. Results DCA combined with ECUR dramatically augmented inhibition of cell survival and enhanced apoptotic induction. The enhanced apoptosis was accompanied by mitochondria-dependent apoptotic signaling activation and corroborated with significant cellular morphological alternations. Conclusion Apoptosis was the major event contributing to the synergistically boosted antiproliferative effect. Coupling DCA treatment with curcumin may rationally be expected to lower the DCA dose needed and relatively reduce accompanying toxicity and oxidative damage while enhancing anticancer potential. This novel 'add-on' approach is, thus, of enormous value to the current DCA therapy.
- Published
- 2018
30. Heat shock protein 27 influences the anti-cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation
- Author
-
Hung Hua Liang, Chien Yu Huang, Ming Te Huang, Yu Jia Chang, Ching Wen Chou, Po Li Wei, and Precious Takondwa Makondi
- Subjects
0301 basic medicine ,endocrine system ,animal structures ,Curcumin ,HSP27 Heat-Shock Proteins ,Antineoplastic Agents ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Hsp27 ,Heat shock protein ,medicine ,Autophagy ,Tumor Cells, Cultured ,Humans ,Propidium iodide ,General Pharmacology, Toxicology and Pharmaceutics ,Protein kinase B ,Heat-Shock Proteins ,chemistry.chemical_classification ,Reactive oxygen species ,biology ,General Medicine ,Cell Cycle Checkpoints ,030104 developmental biology ,chemistry ,Apoptosis ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Colonic Neoplasms ,Cancer research ,biology.protein ,Reactive Oxygen Species ,Oxidative stress ,Molecular Chaperones - Abstract
The problem of therapeutic resistance and chemotherapeutic efficacy is tricky and critical in the management of colorectal cancer (CRC). Curcumin is a promising anti-cancer agent. Heat shock protein 27 (HSP27) is correlated with CRC progression and is said to affect CRC response to different therapies. However, the role of HSP27 on the therapeutic efficacy of curcumin remains unknown. HSP27 was silenced using small hairpin RNA (shRNA) technique. The cytotoxic and apoptotic effects of curcumin were assessed by sulforhodamine B (SRB) colorimetric assay, flow cytometric cell cycle analysis, and annexin V/propidium iodide (PI) double-labeling assays. Total reactive oxygen species (ROS)/superoxide and autophagy detection were performed, and the levels of apoptosis-related proteins were examined by Western blotting. It was found that the silencing of HSP27 (HSP27-KD) resulted in increased treatment resistance to curcumin in CRC cells. In addition, cell cycle analysis showed that the curcumin treatment caused cell cycle arrest at the G2/M phase in the control group, and apoptosis was reduced in the HSP27-KD group. Curcumin treatment also resulted in a decrease in anti-apoptotic proteins, p-Akt, Akt, Bcl-2 and p-Bad, and increase in pro-apoptotic proteins Bad and c-PARP levels in the control cells but not in the HSP27-KD cells. This was also followed by low reactive oxygen/nitrogen species (ROS/RNS), superoxide and autophagy induction levels in the HSP27-KD cells as compared to the control cells. Therefore, as silencing of HSP27 increases curcumin resistance by reducing apoptosis and reactive oxidative stress production, HSP27 is a potential selective target for curcumin treatment in CRC.
- Published
- 2018
31. The effects of type I collagenase on the degelification of chimpanzee (Pan troglodytes) semen plug and sperm quality
- Author
-
Tse-En Wang, Jane-Fang Yu, Yu-Jia Chang, Yu-Syuan Wei, Radhika Joshi, Shih-Chien Chin, Hui-Wen Chang, Yu-Hua Lai, Pei-Shiue Tsai, and Sheng-Hsiang Li
- Subjects
Male ,0301 basic medicine ,endocrine system ,Chimpanzee ,Pan troglodytes ,Collagenase ,Acrosome reaction ,Semen ,Biology ,Semen analysis ,Genetic diversity ,Sperm Preservation ,Andrology ,03 medical and health sciences ,0302 clinical medicine ,Capacitation ,Sperm preservation ,medicine ,Animals ,Collagenases ,Fluorescent Antibody Technique, Indirect ,Acrosome ,reproductive and urinary physiology ,Sperm motility ,lcsh:Veterinary medicine ,030219 obstetrics & reproductive medicine ,General Veterinary ,medicine.diagnostic_test ,urogenital system ,General Medicine ,Spermatozoa ,Sperm ,Semen Analysis ,030104 developmental biology ,lcsh:SF600-1100 ,Research Article - Abstract
Background Semen from the chimpanzee species becomes a colloidal solid after ejaculation. The formation of this copulatory plug is believed to prevent additional spermatozoa of subsequent mating events from accessing the ova. However, this naturally preserved strategy hampers the processes for sperm preparation. In this study, we investigated whether collagenase can be used to degelify the semen plug and accelerate the semen liquefaction process in zoo captive chimpanzee species (Pan troglodytes). Results We showed that incubation of chimpanzee ejaculates with 0.1% type I collagenase efficiently and significantly (p
- Published
- 2018
32. Taiwanofungus camphoratus Combined With Amphotericin B for Metastatic Cancer Patients Unresponsive to or Unwilling to Undergo Chemotherapy: A Pilot Study
- Author
-
Cheng-Jeng, Tai, Yeu-Ching, Shi, Chen-Jei, Tai, Li-Jen, Kuo, Ray-Jade, Chen, Yu-Jia, Chang, Ching, Tzao, Chih-Hsiung, Wu, Chun-Chao, Chang, Hung-Yi, Chiou, and Ching-Hua, Su
- Subjects
Biological Products ,Antifungal Agents ,Treatment Outcome ,Ethanol ,Amphotericin B ,Neoplasms ,Antrodia ,Taiwan ,Humans ,Pilot Projects ,Neoplasm Metastasis ,Retrospective Studies - Abstract
Taiwanofungus camphoratus is a parasitic mushroom found in the heartwood of Cinnamomum kanehirai and is used as a nutritional supplement. It has an anticancer action, both alone and synergistically with amphotericin B (AmB).The study intended to assess the efficacy of a T camphoratus ethanol extract (TCEE) combined with AmB for patients with metastatic cancer whose cancer did not respond to multiline chemotherapy or who were unwilling to receive chemotherapy.The research team performed a retrospective analysis as a pilot study.The study took place at a single hospital (Taipei Medical University Hospital, Taipei, Taiwan).Participants were 9 patients at the hospital who were terminally ill with metastatic cancer.The participants had received daily doses of 2-3 g of the TCEE in combination with a weekly dose of 20-25 mg of AmB in 500 cc of 5% glucose water, given intravenously in 4-6 h.Outcome measures included (1) a primary evaluation index measuring the efficacy of the treatment; (2) a measure of tumor burden that was estimated using the response evaluation criteria in solid tumors (RECIST 1.1), (3) a secondary evaluation index measuring survival duration, and (4) safety.The mean treatment time was 54.4 ± 18.3 wk. At the end of the study, 2 patients showed a continued complete response, 1 patient had a continued partial response, and 1 patient showed a stable disease. The other 5 participants had times to progression ranging from 24 to 48 wk, with a mean of 35.6 wk. The mean survival time was 57.8 ± 18.5 wk, and 5 patients were still alive at the end of the study.For patients whose metastatic cancer did not respond to multiline chemotherapy or who were unwilling to receive chemotherapy, the use of TCEE as an adjuvant therapy to AmB resulted in tumor suppression and a delay in time to disease progression. The preliminary results reported here can be used to guide a future, more extensive clinical study of the combination.
- Published
- 2018
33. Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells
- Author
-
Chien Yu Huang, Wan Li Cheng, Chin Sheng Hung, Yu Jia Chang, and Cheng Jeng Tai
- Subjects
Male ,Cancer Research ,Curcumin ,medicine.drug_class ,Down-Regulation ,Antineoplastic Agents ,Apoptosis ,010501 environmental sciences ,01 natural sciences ,Androgen deprivation therapy ,03 medical and health sciences ,Prostate cancer ,chemistry.chemical_compound ,0302 clinical medicine ,DU145 ,Cell Line, Tumor ,medicine ,Humans ,Gene silencing ,Serpins ,0105 earth and related environmental sciences ,business.industry ,Maspin ,Cancer ,General Medicine ,medicine.disease ,Androgen ,Prostatic Neoplasms, Castration-Resistant ,Oncology ,chemistry ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,Cancer research ,business - Abstract
Background/aim Androgen deprivation therapy remains the principal treatment for patients with advanced prostate cancer, though, most patients will eventually develop hormone-refractory prostate cancer (HRPC). Androgen ablation mediated maspin-induction has been identified in cancer patients. However, the role of maspin on the anticancer activity of curcumin derived from turmeric (Curcuma longa) in HRPC cells has not been elucidated. Materials and methods The anticancer action of curcumin in hormone-independent prostate cancer cells (DU145, and PC-3) was determined by measures of cell survival rate. The cause of maspin silencing on the anti-tumor abilities of curcumin in PC-3 cells was evaluated by measures of cell survival rate, cell-cycle distribution, and apoptosis signaling analysis. Results Our present study showed that PC-3 cells (with higher maspin expression) were more sensitive than DU145 cells to curcumin treatment (with lower maspin expression). RNA interference-mediated maspin silencing reduced curcumin sensitivity of PC-3 cells, as evidenced by reduced apoptotic cell death. After exposure to curcumin, maspin-knockdown cells showed lower expression levels of pro-apoptotic proteins, Bad and Bax, as compared with control cells. Conclusion Maspin can enhance the sensitivity of HRPC cells to curcumin treatment.
- Published
- 2018
34. The GroEL protein ofPorphyromonas gingivalisaccelerates tumor growth by enhancing endothelial progenitor cell function and neovascularization
- Author
-
C. S. Tsai, C. Y. Huang, F. Y. Lin, C. Y. Lin, H. Y. Lu, Yi Wen Lin, Song-Kun Shyue, S. J. Lin, Yu Jia Chang, N. W. Tsao, and C. M. Shih
- Subjects
Male ,Microbiology (medical) ,Nitric Oxide Synthase Type III ,Virulence Factors ,p38 mitogen-activated protein kinases ,Immunology ,Neovascularization, Physiologic ,Inflammation ,Chick Embryo ,p38 Mitogen-Activated Protein Kinases ,Microbiology ,Endothelial progenitor cell ,Mice ,Bacterial Proteins ,Allantois ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Phosphorylation ,Progenitor cell ,General Dentistry ,Porphyromonas gingivalis ,Endothelial Progenitor Cells ,GroEL Protein ,Tube formation ,Mice, Inbred BALB C ,Microscopy, Confocal ,biology ,Chaperonin 60 ,biology.organism_classification ,Molecular biology ,GroEL ,Recombinant Proteins ,Cell biology ,Colonic Neoplasms ,bacteria ,medicine.symptom ,E-Selectin - Abstract
Porphyromonas gingivalis is a bacterial species that causes destruction of periodontal tissues. Additionally, previous evidence indicates that GroEL from P. gingivalis may possess biological activities involved in systemic inflammation, especially inflammation involved in the progression of periodontal diseases. The literature has established a relationship between periodontal disease and cancer. However, it is unclear whether P. gingivalis GroEL enhances tumor growth. Here, we investigated the effects of P. gingivalis GroEL on neovasculogenesis in C26 carcinoma cell-carrying BALB/c mice and chick eggs in vivo as well as its effect on human endothelial progenitor cells (EPC) in vitro. We found that GroEL treatment accelerated tumor growth (tumor volume and weight) and increased the mortality rate in C26 cell-carrying BALB/c mice. GroEL promoted neovasculogenesis in chicken embryonic allantois and increased the circulating EPC level in BALB/c mice. Furthermore, GroEL effectively stimulated EPC migration and tube formation and increased E-selectin expression, which is mediated by eNOS production and p38 mitogen-activated protein kinase activation. Additionally, GroEL may enhance resistance against paclitaxel-induced cell cytotoxicity and senescence in EPC. In conclusion, P. gingivalis GroEL may act as a potent virulence factor, contributing to the neovasculogenesis of tumor cells and resulting in accelerated tumor growth.
- Published
- 2014
35. GRP78 mediates the therapeutic efficacy of curcumin on colon cancer
- Author
-
Chien Yu Huang, Wei Yu Chen, Chin Sheng Hung, Yu Jia Chang, and Po-Li Wei
- Subjects
Curcumin ,Apoptosis ,Biology ,Endoplasmic Reticulum ,HT29 Cells ,chemistry.chemical_compound ,Humans ,Cytotoxic T cell ,MTT assay ,Gene Silencing ,Endoplasmic Reticulum Chaperone BiP ,Heat-Shock Proteins ,Cell Proliferation ,TUNEL assay ,Cell growth ,Cell Cycle ,General Medicine ,Cell cycle ,Molecular biology ,Gene Expression Regulation, Neoplastic ,chemistry ,Colonic Neoplasms ,Cancer research - Abstract
Glucose-regulated protein 78 (GRP78) is the key regulator of endoplasmic reticular (ER) function. Expression of GRP78 was correlated with malignancy in different cancers. However, the role of GRP78 in the cytotoxic effect of curcumin on colon cancer cells is still unclear. A silencing RNA (siRNA) technique was used to knock down GRP78 expression. The anticancer effects of curcumin were assessed by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, a flow cytometric cell cycle analysis, and a terminal dexynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. HT-29 cells expressed lower GRP78 compared with DLD-1 cells. The MTT assay revealed that HT-29 cells were more resistant to curcumin treatment than DLD-1 cells. GRP78KD cells showed more resistance to curcumin treatment compared with scrambled control cells. Overexpressed GRP78 in HT-29 cells increased the sensitivity to curcumin treatment. According to the cell cycle analysis and TUNEL assay, we found that apoptosis dramatically increased in scrambled control cells compared to GRP78KD DLD-1 cells after curcumin treatment. Finally, we evaluated levels of Bcl-2, BAX, and Bad and found that an increase of Bcl-2 level was observed in GRP78KD cells treated with curcumin. Those results were consistent with the increasing of resistance to curcumin after silencing of GRP78. The levels of GRP78 expression might determine the therapeutic efficacy of curcumin against colon cancer cells.
- Published
- 2014
36. Carbonaceous aerosols in the air masses transported from Indochina to Taiwan: Long-term observation at Mt. Lulin
- Author
-
Charles C.-K. Chou, Shuenn Chin Chang, Kai Hsien Chi, Yu Jia Chang, Guo Hau Weng, Horng Wen Chen, Guey Rong Sheu, Sheng Hsiang Wang, Ming Tung Chuang, Chung Te Lee, Chea Yuan Young, Jia Hon Chang, Neng Huei Lin, Shao Peng Hsu, Sin Yu Lai, Hill Huang, Xyue Chang Wu, and Jia Lin Wang
- Subjects
Troposphere ,Total organic carbon ,Atmospheric Science ,Climatology ,Environmental chemistry ,Environmental science ,Collection period ,Biomass burning ,Elemental carbon ,Pressure level ,General Environmental Science ,Aerosol ,Plume - Abstract
Eight carbonaceous fractions from aerosols were resolved using the Interagency Monitoring of Protected Visual Environments (IMPROVE) protocol (Chow et al., 1993). The aerosols were collected at the Mountain Lulin Atmospheric Background Station (Mt. Lulin, 2862 m a.s.l.) in Central Taiwan from April 2003 to April 2012. The monthly and yearly levels of organic carbon (OC) and elemental carbon (EC) varied consistently with PM 2.5 mass concentrations during biomass burning (BB) period. The highest monthly carbonaceous content was observed in March and the highest yearly carbonaceous concentration was observed in 2007. This finding is consistent with the BB activity in Indochina and indicates that carbonaceous content is a major component of BB aerosols. Lee et al. (2011) classified four trajectory groups from the air masses transported to Mt. Lulin during the aerosol collection period. For the air masses transported from the BB area (the BB group) in Indochina, the carbonaceous content was greater than the water-soluble ions in PM 2.5 , and the OC/EC ratio (4.8 ± 1.5) was high. With EC as the indicator of primary emission sources, the air masses of the BB group were found to contain more primary than secondary OC. The Anthropogenic group (from the local and free troposphere below the 700-hPa pressure level over the Asian continent) probably contained more secondary than primary OC or the sources of OC and EC could be quite diverse. The average char-EC/soot-EC (low-temperature EC/high-temperature EC) ratios were 3.9 ± 3.5, 0.4 ± 0.4, 0.9 ± 0.8, and 0.3 ± 0.4 for the trajectory groups BB , SNBB (from BB source areas during the non-BB period), Anthropogenic , and FT (from the oceanic area and the free troposphere above the 700-hPa pressure level over the Asian continent), respectively. The presence of a high char-EC/soot-EC ratio confirmed the correct classification of the BB group, whereas the low ratios from the other groups indicated the strong influence of vehicle exhaust. It is noted that higher OC and EC levels were obtained at Mt. Lulin as compared with those obtained at other high-elevation sites. This difference suggested that the Indochina BB plume exhibited a more serious climatic impact on the background air in East Asia than in other places in Asia and Europe. On the basis of the carbonaceous levels of the SNBB and FT groups, the background OC and EC levels of approximately 3000 m in the West Pacific are around 1.33 μg m −3 and 0.35 μg m −3 , respectively.
- Published
- 2014
37. Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers
- Author
-
Hui Hsiung Liu, Jun Jen Liu, Yu Jia Chang, Chun-Te Wu, Po Li Wei, Weu Wang, and Miao Fen Chen
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Epithelial-Mesenchymal Transition ,Thrombomodulin ,Vimentin ,Metastasis ,Prostate cancer ,Cell Movement ,Cell Line, Tumor ,medicine ,Humans ,Epithelial–mesenchymal transition ,Cell adhesion ,Cell Proliferation ,biology ,Cell growth ,Prostatic Neoplasms ,Cell migration ,General Medicine ,Cadherins ,medicine.disease ,Cancer research ,biology.protein ,Calcium ,Biomarkers - Abstract
Thrombomodulin (TM) is highly expressed in endothelial cells and plays the key role in maintaining physical homeostasis. In addition, many pieces of evidence also show that TM contains the diagnostic value for malignant diseases. TM has been found to correlate with metastatic status in multiple cancers, but its role in prostate cancer progression remains unclear. TM expression was determined in prostate cancer cells (DU-145 and PC-3 cells) using real-time PCR and Western blotting. TM expression was manipulated in prostate cancer cells using TM-specific shRNA and an overexpression system. The proliferation, adhesion, and migratory ability of prostate cancer cells expressing various TM levels were determined using the x'Celligence biosensor system and a transwell migration assay. Higher levels of TM transcription and translation were found in DU-145 cells and were negatively correlated with the low migratory ability of DU-145 cells. After silencing TM expression in DU-145 cells, cell growth decreased, but cell adhesion and migration dramatically increased. TM overexpression in PC-3 cells reduced their metastatic ability. We investigated the possible mechanisms of this phenomenon and determined that the enhanced cell migration was mediated through the expression of E-cadherin and vimentin. TM may be a modulator of hormone-independent prostate cancer (HIPC) metastasis. The downregulation of TM expression enhanced the migratory ability of these cells via an increase in vimentin expression and a decrease in E-cadherin expression.
- Published
- 2014
38. Abstract LB-209: Novel pathway prediction for colorectal cancer to liver metastasis through bioinformatics
- Author
-
Chien-Yu Huang, Precious Takondwa Makondi, and Yu Jia Chang
- Subjects
Cancer Research ,MMP2 ,Colorectal cancer ,Cancer ,Biology ,medicine.disease ,Bioinformatics ,Exosome ,Metastasis ,Oncology ,Gene interaction ,microRNA ,medicine ,Extracellular matrix organization - Abstract
Background: Liver metastases are the most common cause of colorectal cancer (CRC) related deaths, with no reliable clinical predictors. Therefore, identifying potential candidate predictors is crucial for clinical application and management. Methodology: The Gene Expression Omnibus (GEO) datasets GSE49355, GSE41258 and GSE81558 for genes and GSE54088 and GSE56350 for miRNAs were used to identify common differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) between paired primary CRC tissues and the corresponding liver metastatic tissues. Then, DEMs targets were identified from DEGs. These were verified in GEO datasets comprising gene, miRNA and miRNA exosome profiles of CRC patients with no distant metastases (M0) and distant metastases (M1); the interaction networks and pathways were also mapped. Results: There were 49 upregulated and 13 downregulated DEGs, and 16 downregulated and 14 upregulated DEMs; between DEGs and DEMs targets, there were five upregulated and four downregulated genes. MiR-20a was significantly high in M1, with the combination of MiR-20a, -495, -576-5p and -449a offering a superior prediction value (sensitivity of 83.3%, specificity of 63.8%, AUC of 0.725). In miRNA exosomes, MiR-576-5p was significantly low in M1, while MiR-20a and -449a were highly expressed, and combination of miR-20a, -495, -576-5p, -449a, -619 and -382 provided best predictive value (sensitivity=75.0%, specificity=88.2%, AUC=0.875). The miRNA target CDH2 was significantly highly expressed in M1 while KNG1 and MMP2 were lowly expressed. The miRNA to gene interaction model was demonstrated, and enriched pathways were; regulation of IGF transport and uptake by IGFBPs, extracellular matrix organization, signal transduction and immune system. Conclusion: This model predicts novel pathway for predicting CRC to liver metastases. This may be clinically applicable. Citation Format: Precious Takondwa Makondi, Chien-Yu Huang, Yu-Jia Chang. Novel pathway prediction for colorectal cancer to liver metastasis through bioinformatics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr LB-209.
- Published
- 2019
39. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy
- Author
-
Yu Jia Chang, Chien Yu Huang, and Po Li Wei
- Subjects
0301 basic medicine ,Embryology ,Cancer Treatment ,Autophagy-Related Proteins ,Apoptosis ,medicine.disease_cause ,chemistry.chemical_compound ,0302 clinical medicine ,Superoxides ,Medicine and Health Sciences ,Zebrafish ,Propyl gallate ,Multidisciplinary ,Cell Death ,Liver Diseases ,Liver Neoplasms ,Eukaryota ,Oxides ,Animal Models ,Chemistry ,Oncology ,Experimental Organism Systems ,Cell Processes ,Osteichthyes ,030220 oncology & carcinogenesis ,Physical Sciences ,Vertebrates ,Medicine ,Cellular Structures and Organelles ,Intracellular ,Research Article ,Carcinoma, Hepatocellular ,Autophagic Cell Death ,Science ,ATG5 ,Gastroenterology and Hepatology ,Research and Analysis Methods ,Carcinomas ,03 medical and health sciences ,Model Organisms ,Cell Line, Tumor ,Gastrointestinal Tumors ,Autophagy ,medicine ,Animals ,Humans ,Propyl Gallate ,Cell Proliferation ,Cell growth ,Embryos ,Chemical Compounds ,Organisms ,Biology and Life Sciences ,Cancers and Neoplasms ,Cell Biology ,Hepatocellular Carcinoma ,Xenograft Model Antitumor Assays ,Fish ,030104 developmental biology ,chemistry ,Cancer cell ,Animal Studies ,Cancer research ,Lysosomes ,Apoptosis Regulatory Proteins ,Reactive Oxygen Species ,Oxidative stress ,Developmental Biology - Abstract
The poor prognosis of hepatocellular carcinoma (HCC) has been attributed to a high frequency of tumor metastasis and recurrence even after successful surgical resection. With less than 30% of patients benefiting from curative treatment, alternative treatment regimens for patients with advanced HCC are needed. Propyl gallate (PG), a synthetic antioxidant used in preserving food and medicinal preparations, has been shown to induce cancer cell death, but the anticancer effects of PG in HCC are unclear. In the present study, we demonstrated that PG inhibited HCC cell proliferation in vitro and in zebrafish models in vivo in a dose- and time-dependent manner. PG also induced cell apoptosis and increased the number of necrotic cells in a time- and dose-dependent manner as determined using a high-content analysis system. We found that PG also increased the intracellular levels of superoxide and reactive oxidative stress as well as the formation of autophagosomes and lysosomes. Regarding the molecular mechanism, PG did not alter the levels of autophagy-related 5 (ATG5), ATG5/12 or Beclin-1 but increased the rate of the LC3-I to LC3-II conversion, suggesting autophagy induction. PG exposure increased the levels of the pro-apoptotic proteins cleaved caspase-3, cleaved PARP, Bax, and Bad and a decreased level of the anti-apoptotic protein Bcl-2. In conclusion, we demonstrate that PG inhibits HCC cell proliferation through enhanced ROS production and autophagy activation. Finally, PG-treated cells induced cell apoptosis and may be a new candidate for HCC therapy.
- Published
- 2019
40. Silencing Heat Shock Protein 27 Inhibits the Progression and Metastasis of Colorectal Cancer (CRC) by Maintaining the Stability of Stromal Interaction Molecule 1 (STIM1) Proteins
- Author
-
Yu Jia Chang, Wei Yu Chen, Chien-Yu Huang, Po-Li Wei, and Wei Chiao Chang
- Subjects
0301 basic medicine ,endocrine system ,animal structures ,STIM1 ,Colorectal cancer ,Immunoprecipitation ,HSP27 ,urologic and male genital diseases ,Article ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Hsp27 ,Heat shock protein ,Medicine ,Gene silencing ,lcsh:QH301-705.5 ,Gene knockdown ,biology ,business.industry ,General Medicine ,medicine.disease ,CRC ,030104 developmental biology ,ER ,lcsh:Biology (General) ,Tumor progression ,030220 oncology & carcinogenesis ,embryonic structures ,Cancer research ,biology.protein ,business ,SOCE - Abstract
The incidence of colorectal cancer (CRC) has significantly increased in recent decades, and this disease has become an important health issue worldwide. Currently, there is no useful prognostic or diagnostic biomarker for CRC. Heat shock protein 27 (HSP27) is a chaperone that interacts with many proteins. HSP27 has been shown to be overexpressed in many cancers, including colon cancer, and its overexpression is related to poor disease outcome. Although the importance of HSP27 as a biomarker cannot be underrated, its detailed mechanisms in colon cancer are still unclear. In vitro studies have indicated that silencing HSP27 reduces the proliferation, migration and invasion of colon cancer cells, and xenograft models have shown that silencing HSP27 decreases tumor progression. Tissue array results showed that colon cancer patients with high expression of HSP27 exhibited poor prognosis. In addition, we found a reduction of calcium influx through a decrease in STIM1 protein after HSP27 was abolished. The formation of puncta was decreased in HSP27 knockdown (HSP27KD) cells after thapsigargin (TG) treatment. Finally, we confirmed that the reduction of STIM1 after HSP27 silencing may be due to a loss of STIM1 stability instead of transcription. HSP27 may interact with STIM1 but not Orai1, as shown by immunoprecipitation assays. HSP27 and STIM1 were co-expressed in CRC specimens. Our study showed that HSP27 is a key mediator in the progression and metastasis of CRC by regulating the store-operated calcium entry. This novel pathway may provide a new direction for development of therapeutic strategies for CRC.
- Published
- 2018
41. Shikonin Suppresses the Migratory Ability of Hepatocellular Carcinoma Cells
- Author
-
Jun Jen Liu, Hou Yu Su, Ching Hsein Chen, Chun-Te Wu, Yuan Soon Ho, Po Li Wei, Wei Yu Chen, Chao Chiang Tu, and Yu Jia Chang
- Subjects
Carcinoma, Hepatocellular ,Cell ,Vimentin ,Biology ,Downregulation and upregulation ,Cell Movement ,Cell Line, Tumor ,medicine ,Humans ,MTT assay ,Neoplasm Metastasis ,Endoplasmic Reticulum Chaperone BiP ,IC50 ,Protein kinase B ,Lithospermum ,Liver Neoplasms ,General Chemistry ,Gene Expression Regulation, Neoplastic ,Blot ,medicine.anatomical_structure ,Matrix Metalloproteinase 9 ,Biochemistry ,Cell culture ,Cancer research ,biology.protein ,Matrix Metalloproteinase 2 ,General Agricultural and Biological Sciences ,Drugs, Chinese Herbal ,Naphthoquinones - Abstract
Shikonin is a traditional Oriental medical herb extracted from Lithospermum erythrorhizon. Many studies have shown that shikonin possesses anticancer ability against many different cancers, including hepatocellular carcinoma (HCC). Recently, tumor metastasis has been become an important clinical obstacle. However, the effect of shikonin on metastasis by HCC is unknown. The 50% inhibitory concentration (IC50) of shikonin on HCC cells was determined by an MTT assay and the xCELLigence biosensor system. The migratory ability of HCC cells was detected by a transwell migration assay and the xCELLigence biosensor system. Matrix metalloproteinase-2 and -9 (MMP-2 and -9) expression levels were determined by Western blotting, and the activities of MMP-2 and -9 were determined by gelatin zymography. We found that IC50 values of HepJ5 and Mahlavu cells to shikonin treatment were around 2 μM. Exposure to a low dose of shikonin (0-0.4 μM) did not influence the survival of HCC cells. Interestingly, exposure to a low dose of shikonin inhibited the migratory ability on HepJ5 and Mahlavu cells. To further dissect the mechanism, we found that treatment with a low dose of shikonin reduced the activities and expression levels of MMP-2 and -9, which were correlated with the decreased cell migratory ability of HCC cells. In addition, we found a decrease of vimnetin expression, but no influence on the expression levels of N-cadherin, TWIST, or GRP78. In mechanism dissecting, we found that shikonin treatment may suppress the phosphorylation of AKT and then reduce the NF-κB (NF = nuclear factor) levels, but has no influence on the levels of c-Fos and c-Jun. Furthermore, we also found that shikonin may also reduce the phosphorylation of IκB. We concluded that a low dose of shikonin can suppress the migratory ability of HCC cells through downregulation of expression levels of vimentin and MMP-2 and -9. Our findings suggest that shikonin may be a new compound to prevent the migration of HCC cells.
- Published
- 2013
42. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression
- Author
-
Hou Yu Su, Yu Jia Chang, Wen Ching Wang, Chih Hsiung Wu, Miao Fen Chen, Hui Hsiung Liu, Chun-Te Wu, and Wei Yu Chen
- Subjects
Male ,Small interfering RNA ,Glucose-regulated protein ,Metastasis ,Prostate cancer ,Downregulation and upregulation ,Cell Movement ,Cell Line, Tumor ,Cell Adhesion ,medicine ,Humans ,Gene silencing ,Gene Silencing ,Neoplasm Metastasis ,Endoplasmic Reticulum Chaperone BiP ,Heat-Shock Proteins ,Serpins ,Cell Proliferation ,biology ,Maspin ,Prostatic Neoplasms ,Cell migration ,General Medicine ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Cyclooxygenase 2 ,Immunology ,Disease Progression ,Cancer research ,biology.protein - Abstract
Glucose-regulated protein 78 (GRP78) plays an essential role in embryonic development and in the progression and therapeutic resistance of many cancers. However, little is known about the function of GRP78 in hormone-independent prostate cancer. Here, we found that the expression levels of GRP78 were higher in PC-3 cells than in DU-145 cells. When the expression of GRP78 was silenced using a GRP78-specific small interfering RNA in PC-3 cells, the growth rate and adhesive ability were reduced. Cell migration was dramatically decreased in GRP78-depleted cells. Dissection of the involved signal pathways revealed that maspin expression was upregulated after silencing GRP78 expression. The upregulation of maspin and downregulation of COX-2 may cause the decrease in cell proliferation and migration observed after silencing GRP78 expression. Silencing GRP78 expression may suppress the proliferation, adhesion, and migration of prostate cancer cells via maspin and COX-2 regulation.
- Published
- 2013
43. Thrombomodulin mediates the progression of epithelial ovarian cancer cells
- Author
-
Chien Kai Wang, Yu Jia Chang, Ming Te Huang, Chun-Te Wu, Weu Wang, Feng Hsiang Chiu, Lu Min Chen, Cheng Jeng Tai, Chen Jei Tai, and Jen Chih Lee
- Subjects
Cell Survival ,Thrombomodulin ,Blotting, Western ,Biology ,medicine.disease_cause ,Metastasis ,Small hairpin RNA ,Cell Movement ,Cell Line, Tumor ,Biomarkers, Tumor ,medicine ,Humans ,Vimentin ,Gene silencing ,Neoplasms, Glandular and Epithelial ,Cell Proliferation ,Ovarian Neoplasms ,Migration Assay ,Reverse Transcriptase Polymerase Chain Reaction ,Cell growth ,General Medicine ,medicine.disease ,Fibronectins ,Gene Expression Regulation, Neoplastic ,Cancer research ,Female ,RNA Interference ,Carcinogenesis ,Ovarian cancer - Abstract
Thrombomodulin (TM), a natural anticoagulation factor, maintains circulation homeostasis in endothelial cells. TM has additional roles in modulating inflammation, thrombosis, and carcinogenesis. However, there is little information on the role of TM in the progression and metastasis of ovarian cancer. RNA silencing and cDNA expression vectors were used to manipulate target gene expression in ovarian cancer cells. Cell growth and migration were evaluated by an MTT assay, a wound-healing migration assay, a transwell migration assay, and a biosensor system. In this study, we found that TM silencing may enhance the growth rate of cells. The migratory ability of ovarian cancer cells was enhanced dramatically after TM silencing. TM overexpression in ovarian cells suppressed the proliferation and migration capability. Furthermore, we found that skov-3 cells treated with TM shRNA expressed high levels of fibronectin and vimentin and that the expression of these markers correlated positively with their migratory ability. Our results demonstrate that TM expression may regulate cell growth and migration in ovarian cancer cells. This finding suggests that TM may be a novel prognostic and therapeutic target for ovarian cancer.
- Published
- 2013
44. Intersphincteric resection for very low rectal cancer: clinical outcomes of open versus laparoscopic approach and multidimensional analysis of the learning curve for laparoscopic surgery
- Author
-
Yu Jia Chang, Ka Wai Tam, Weu Wang, Chin Sheng Hung, Ming Te Huang, Hung Chia Lee, Li Jen Kuo, Hung Hua Liang, and Po Li Wei
- Subjects
Adult ,Male ,Laparoscopic surgery ,medicine.medical_specialty ,Colorectal cancer ,medicine.medical_treatment ,Operative Time ,Blood Loss, Surgical ,Anal Canal ,Proctoscopy ,Professional Competence ,Low rectal cancer ,Blood loss ,medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Rectal Neoplasms ,business.industry ,Middle Aged ,medicine.disease ,Intersphincteric resection ,Surgery ,Sphincter preservation ,Dissection ,Treatment Outcome ,Learning curve ,Female ,Laparoscopy ,business ,Learning Curve - Abstract
Laparoscopic rectal cancer surgery is regarded as more complex because of its technical difficulties in pelvic exposure, dissection, and sphincter preservation. This study therefore aimed to investigate the feasibility of laparoscopic resection for low rectal cancer using intersphincteric resection (ISR) and to assess its short-term oncological outcomes. Further, we intended to analyze the learning curve for laparoscopic surgery and identify the factors influencing the learning curve.Patients with low rectal cancer who received open or laparoscopic ISR were retrospectively chart reviewed. The surgical and oncological outcomes were evaluated. Comparisons of operating time, estimated blood loss, surgical outcomes, and histopathologic status were analyzed. Also, operating time was used as a technical indicator for learning curve analysis.The mean estimated blood loss was 265 mL (range, 100-800 mL) in the open group and 104 mL (range, 30-250 mL) in the laparoscopic group. There was a significant difference between these two groups (P 0.001). Operative experience analysis showed that the mean operating time was 402.1 min (range, 210-570 min) in the first stage and 331.4 min (range, 210-450 min) in the second stage, and on pathologic examination the mean number of lymph nodes harvested was 11.1 (range, 5-21) in the first stage and 18.3 (range, 11-31) in the second stage, with statistical differences between these two stages (P = 0.034 and P = 0.004, respectively). Multifactorial analysis showed that operating time was associated with surgeons' experience (18 or ≥18 cases) (odds ratio = 2.918, 95% CI 1.078-7.902). Protective stoma creation was also associated with surgeons' experience (odds ratio = 3.999, 95% CI 1.153-13.86).Our data show that laparoscopic ISR for low rectal cancer is feasible and safe. Surgeons' experience improved operating time and postoperative complications.
- Published
- 2013
45. New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
- Author
-
Kuo Pao Lai, Chawnshang Chang, Chin Ying Chung, Chiung-Kuei Huang, Yu Jia Chang, Shinichi Yamashita, Shuyuan Yeh, Soo Ok Lee, and Lei Li
- Subjects
Male ,medicine.medical_specialty ,Curcumin ,Transcription, Genetic ,Nuclear Receptor Coactivators ,Mice, Nude ,Antineoplastic Agents ,Biology ,urologic and male genital diseases ,Chemoprevention ,Pathology and Forensic Medicine ,Androgen deprivation therapy ,Mice ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Cell Line, Tumor ,Internal medicine ,LNCaP ,medicine ,Animals ,Humans ,Castration ,030304 developmental biology ,0303 health sciences ,Cell growth ,Androgen binding ,Intracellular Signaling Peptides and Proteins ,PTEN Phosphohydrolase ,Prostate ,Prostatic Neoplasms ,Regular Article ,Epithelial Cells ,LIM Domain Proteins ,medicine.disease ,Xenograft Model Antitumor Assays ,Androgen receptor ,Disease Models, Animal ,Endocrinology ,Receptors, Androgen ,030220 oncology & carcinogenesis ,Proteolysis ,Cancer research ,Prostate surgery ,Tramp - Abstract
Using androgen receptor (AR) knockout mice to determine AR functions in selective prostate cancer (PCa) cells, we determined that AR might play differential roles in various cell types, either to promote or suppress PCa development/progression. These observations partially explain the failure of current androgen deprivation therapy (ADT) to reduce/prevent androgen binding to AR in every cell. Herein, we identified the AR degradation enhancer ASC-J9, which selectively degrades AR protein via interruption of the AR-AR selective coregulator interaction. Such selective interruption could, therefore, suppress AR-mediated PCa growth in the androgen-sensitive stage before ADT and in the castration-resistant stage after ADT. Mechanistic dissection suggested that ASC-J9 could activate the proteasome-dependent pathway to promote AR degradation through the enhanced association of AR-Mdm2 complex. The consequences of ASC-J9-promoted AR degradation included reduced androgen binding to AR, AR N-C terminal interaction, and AR nuclear translocation. Such inhibitory regulation could then result in suppression of AR transactivation and AR-mediated cell growth in eight different mouse models, including intact or castrated nude mice xenografted with androgen-sensitive LNCaP cells or androgen-insensitive C81 cells and castrated nude mice xenografted with castration-resistant C4-2 and CWR22Rv1 cells, and TRAMP and Pten(+/-) mice. These results demonstrate that ASC-J9 could serve as an AR degradation enhancer that effectively suppresses PCa development/progression in the androgen-sensitive and castration-resistant stages.
- Published
- 2013
46. Aqueous Extract ofSolanum nigrumLeaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells
- Author
-
Chun Chao Chang, Yi Feng Lin, Chien Kai Wang, Yu Jia Chang, Chen Jei Tai, Cheng Jeng Tai, Jiun Yu Jian, and Chi Shian Lin
- Subjects
Cisplatin ,Chemotherapy ,Article Subject ,Colorectal cancer ,business.industry ,medicine.medical_treatment ,Cancer ,lcsh:Other systems of medicine ,Pharmacology ,lcsh:RZ201-999 ,medicine.disease ,Complementary and alternative medicine ,Docetaxel ,Fluorouracil ,medicine ,Doxorubicin ,Cytotoxicity ,business ,Research Article ,medicine.drug - Abstract
Colorectal cancer is a common cancer worldwide, and chemotherapy is a mainstream approach for advanced and recurrent cases. Development of effective complementary drugs could help improve tumor suppression efficiency and control adverse effects from chemotherapy. The aqueous extract ofSolanum nigrumleaves (AE-SN) is an essential component in many traditional Chinese medicine formulas for treating cancer, but there is a lack of evidence verifying its tumor suppression efficacy in colorectal cancer. The purpose of this study is to evaluate the tumor suppression efficacy of AE-SN using DLD-1 and HT-29 human colorectal carcinoma cells and examine the combined drug effect when combined with the chemotherapeutic drugs cisplatin, doxorubicin, docetaxel, and 5-fluorouracil. The results indicated that AE-SN induced autophagy via microtubule-associated protein 1 light chain 3 A/B II accumulation but not caspase-3-dependent apoptosis in both cell lines. The IC50s after 48 hours of treatment were 0.541 and 0.948 mg/ml AE-SN in DLD-1 and HT-29, respectively. AE-SN also demonstrated a combined drug effect with all tested drugs by enhancing cytotoxicity in tumor cells. Our results suggest that AE-SN has potential in the development of complementary chemotherapy for colorectal cancer.
- Published
- 2013
47. Moderate to High Concentrations of High-Density Lipoprotein From Healthy Subjects Paradoxically Impair Human Endothelial Progenitor Cells and Related Angiogenesis by Activating Rho-Associated Kinase Pathways
- Author
-
Ryuichi Morishita, Chun Ming Shih, Chun Yao Huang, Yu Jia Chang, Hironori Nakagami, Heng Kien Au, Jaw Wen Chen, Feng Yen Lin, Nen Chung Chang, and Kou Gi Shyu
- Subjects
Male ,medicine.medical_specialty ,Cell Survival ,Angiogenesis ,Neovascularization, Physiologic ,Mice, SCID ,In Vitro Techniques ,Biology ,Nitric Oxide ,p38 Mitogen-Activated Protein Kinases ,Mice ,Phosphatidylinositol 3-Kinases ,Young Adult ,Internal medicine ,Diabetes Mellitus ,medicine ,Animals ,Humans ,Protein kinase A ,Rho-associated protein kinase ,Protein kinase B ,Cells, Cultured ,Cellular Senescence ,Tube formation ,rho-Associated Kinases ,Dose-Response Relationship, Drug ,Kinase ,Stem Cells ,Lipoproteins, LDL ,Disease Models, Animal ,Endocrinology ,Immunology ,Endothelium, Vascular ,Lipoproteins, HDL ,Cardiology and Cardiovascular Medicine ,Proto-Oncogene Proteins c-akt ,Cell aging ,Signal Transduction ,Lipoprotein - Abstract
Objective— Recent clinical evidence has failed to demonstrate the benefits of elevation of serum high-density lipoprotein (HDL), suggesting potential loss of protective effects of HDL at high concentrations. This study aimed to investigate the concentration-related effects of HDL on in vitro and in vivo functions of human endothelial progenitor cells (EPCs) and related angiogenesis. Methods and Results— Early and late outgrowth EPCs were generated from human circulating mononuclear cells. Oxidized low-density lipoprotein reduced viability of late outgrowth EPCs, which was reversed dose dependently by HDL. In the absence of oxidized low-density lipoprotein, HDL at low concentrations (5–50 μg/mL, equal to 0.5–5 mg/dL in human) enhanced EPC tube formation by activating phosphatidylinositol-3 kinase/Akt/endothelial NO synthase pathways. Moderate to high concentrations (400–800 μg/mL) of HDL paradoxically enhanced EPC senescence and impaired tube formation by activating Rho-associated kinase (ROCK) and inhibiting phosphatidylinositol-3 kinase/Akt and p38 mitogen-activated protein kinase pathways. Rho-associated kinase inhibitors, either Y27632 or statins, prevented high HDL–induced EPC senescence and improved in vitro tube formation, as well as in vivo capacity of angiogenesis of EPCs. Conclusion— While protecting EPCs from the injury of oxidized low-density lipoprotein, moderate to high concentrations of HDL paradoxically impaired EPCs and related angiogenesis in the absence of oxidized low-density lipoprotein by activating Rho-associated kinase pathways, providing mechanistic evidence of potential hazard effects of HDL.
- Published
- 2012
48. Ursolic Acid Attenuates HMGB1-induced LOX-1 Expression in Vascular Endothelial Cells in vitro and Inhibits Atherogenesis in Hypercholesterolemic Mice in vivo
- Author
-
Yu Jia Chang, Chun Ming Shih, Yi Wen Lin, Nen Chung Chang, Tsorng Harn Fong, Feng Yen Lin, Chi Yuan Li, Chih Hao Nien, Nai Wen Tsao, Ai Wei Lee, Yung-Hsiang Chen, and Chun Yao Huang
- Subjects
Pharmacology ,chemistry.chemical_compound ,Biochemistry ,biology ,Ursolic acid ,In vivo ,Chemistry ,Endocrinology, Diabetes and Metabolism ,biology.protein ,Immunology and Allergy ,HMGB1 ,In vitro ,Cell biology - Published
- 2012
49. Hypermethylation of
- Author
-
Ruo-Kai, Lin, Wan-Yu, Hung, Yu-Fang, Huang, Yu-Jia, Chang, Chien-Hsing, Lin, Wei-Yu, Chen, Shih-Feng, Chiu, Shih-Ching, Chang, and Shih-Feng, Tsai
- Subjects
DNA methylation ,BEND5 ,colorectal cancer ,tumor suppressor genes ,prognostic marker ,Research Paper - Abstract
Aberrant hypermethylation of CpG islands in tumor suppressor genes (TSGs) contributes to colorectal tumorigenesis. To identify new colorectal cancer (CRC) screening marker, we investigated DNA methylation alterations in novel TSGs. Using HumanMethylation450 BeadChip arrays, CpG regions in BEND5 were the most highly methylated among all genomic regions in 26 colorectal tumors compared to paired non-neoplastic tissues from a Taiwan cohort. Therefore, BEND5 was selected for further analysis. Quantitative methylation-specific real-time PCR revealed that 86.7% (117/135) of CRC patients exhibited hypermethylated BEND5. Real-time reverse transcription PCR identified that BEND5 mRNA expression was downregulated in 68% (32/47) of the analyzed samples. BEND5 hypermethylation was associated with poor overall survival (OS) in Taiwan patients with early-stage CRC (P = 0.037). In a CRC tissue set from South Korea, OS was higher in patients with high BEND5 protein expression than in those with low BEND5 protein expression (P = 0.037) by using immunohistochemistry assays. Consistently, BEND5 hypermethylation was associated with poor OS in patients with early-stage CRC in The Cancer Genome Atlas (TCGA) data set (P = 0.003). Multivariate Cox proportional hazards regression analysis further supported that hypermethylation of BEND5 genes was significantly associated with OS in Taiwan and TCGA CRC patients (P = 0.023 and 0.033, respectively). Finally, the cell model assay with transient transfection of BEND5 or si-BEND5 knockdown indicated that BEND5 inhibited cancer cell proliferation. In conclusion, epigenetic alteration in the candidate TSG BEND5 contributes to colorectal cancer development and is a prognostic marker of CRC.
- Published
- 2016
50. Low Complexity Approach of Material and Relative Appearance Detection for Beverage Cup
- Author
-
Yu-Jia Chang, Lawrence Y. Deng, and Dong Liang Lee
- Subjects
Low complexity ,Engineering ,business.industry ,Recognition system ,Image processing ,Computer vision ,Absolute difference ,Artificial intelligence ,Food culture ,business ,Time cost ,Edge detection ,Feature detection (computer vision) - Abstract
The beverage cups influence food culture and environmental issues. EPA announced that the amount of beverage cup amounted to 1.5 billion in the 2011, and gradually pays attention to this problem. The beverage cups include the paper, PP, PS, PLA, PET etc. In this paper, we proposed an image-based recognition system to detect the beverage cup. These methodologies contained the image processing techniques and simple geometric operations to find the appearance of the cup, such as cup cover, straws, cup body. The image processing technologies contained the gray level transformation, Gaussian distribution and edge detection (Canny). Furthermore, we use the image matching approach based on Sum of Absolute Difference (SAD) to find the corresponding material. It can improve recycle efficiency, saving the labour power of beverage cup recycle, and making a contribution to the environment and recycle. The average time cost was 103ms. The accuracy rates were: straw 90%, PLA 66%, PP 95%, PS 100%, PAPER 100%.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.